Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032501 | 0.00000 | 1.90686 | 359 | 491 | 7751 | multicellular organismal process |
| GO:0048856 | 0.00000 | 1.86229 | 277 | 398 | 5988 | anatomical structure development |
| GO:0007275 | 0.00000 | 1.86997 | 254 | 372 | 5491 | multicellular organism development |
| GO:0048731 | 0.00000 | 1.87114 | 228 | 340 | 4918 | system development |
| GO:0050896 | 0.00000 | 1.82558 | 432 | 553 | 9324 | response to stimulus |
| GO:0032502 | 0.00000 | 1.80745 | 297 | 414 | 6411 | developmental process |
| GO:0022610 | 0.00000 | 2.40923 | 66 | 137 | 1427 | biological adhesion |
| GO:0007155 | 0.00000 | 2.37749 | 66 | 135 | 1420 | cell adhesion |
| GO:0006954 | 0.00000 | 2.79392 | 39 | 95 | 848 | inflammatory response |
| GO:0030198 | 0.00000 | 3.96819 | 17 | 57 | 368 | extracellular matrix organization |
| GO:0043062 | 0.00000 | 3.51728 | 20 | 59 | 422 | extracellular structure organization |
| GO:0008283 | 0.00000 | 2.02189 | 94 | 165 | 2024 | cell proliferation |
| GO:0023052 | 0.00000 | 1.67429 | 307 | 409 | 6620 | signaling |
| GO:0007154 | 0.00000 | 1.65505 | 308 | 408 | 6647 | cell communication |
| GO:0046903 | 0.00000 | 2.08653 | 77 | 141 | 1661 | secretion |
| GO:0051716 | 0.00000 | 1.63316 | 353 | 453 | 7617 | cellular response to stimulus |
| GO:0048513 | 0.00000 | 1.74397 | 166 | 248 | 3583 | animal organ development |
| GO:0051239 | 0.00000 | 1.76620 | 151 | 230 | 3260 | regulation of multicellular organismal process |
| GO:0009605 | 0.00000 | 1.84253 | 117 | 188 | 2520 | response to external stimulus |
| GO:0040011 | 0.00000 | 1.93132 | 92 | 156 | 1977 | locomotion |
| GO:0007166 | 0.00000 | 1.76829 | 141 | 217 | 3052 | cell surface receptor signaling pathway |
| GO:0006952 | 0.00000 | 1.96915 | 83 | 145 | 1797 | defense response |
| GO:0030154 | 0.00000 | 1.67394 | 196 | 280 | 4239 | cell differentiation |
| GO:0032940 | 0.00000 | 2.04145 | 71 | 128 | 1524 | secretion by cell |
| GO:0048869 | 0.00000 | 1.65505 | 205 | 289 | 4431 | cellular developmental process |
| GO:0042127 | 0.00000 | 1.97392 | 79 | 138 | 1700 | regulation of cell proliferation |
| GO:0032879 | 0.00000 | 1.76576 | 132 | 204 | 2853 | regulation of localization |
| GO:0070887 | 0.00000 | 1.71853 | 152 | 227 | 3281 | cellular response to chemical stimulus |
| GO:0048583 | 0.00000 | 1.64672 | 201 | 283 | 4342 | regulation of response to stimulus |
| GO:0007267 | 0.00000 | 1.96962 | 76 | 134 | 1650 | cell-cell signaling |
| GO:0006928 | 0.00000 | 1.84282 | 103 | 167 | 2213 | movement of cell or subcellular component |
| GO:0006811 | 0.00000 | 1.94270 | 79 | 136 | 1696 | ion transport |
| GO:0032101 | 0.00000 | 2.29864 | 42 | 87 | 913 | regulation of response to external stimulus |
| GO:0098609 | 0.00000 | 2.35847 | 39 | 82 | 839 | cell-cell adhesion |
| GO:0001503 | 0.00000 | 3.07753 | 18 | 50 | 398 | ossification |
| GO:0009653 | 0.00000 | 1.74913 | 127 | 195 | 2735 | anatomical structure morphogenesis |
| GO:0002376 | 0.00000 | 1.70164 | 148 | 220 | 3193 | immune system process |
| GO:0001775 | 0.00000 | 1.99053 | 67 | 119 | 1440 | cell activation |
| GO:0016477 | 0.00000 | 1.93856 | 74 | 128 | 1592 | cell migration |
| GO:0042221 | 0.00000 | 1.58835 | 222 | 302 | 4797 | response to chemical |
| GO:0048870 | 0.00000 | 1.88781 | 81 | 137 | 1751 | cell motility |
| GO:0051674 | 0.00000 | 1.88781 | 81 | 137 | 1751 | localization of cell |
| GO:0051049 | 0.00000 | 1.84988 | 87 | 144 | 1879 | regulation of transport |
| GO:0051240 | 0.00000 | 1.86447 | 84 | 140 | 1811 | positive regulation of multicellular organismal process |
| GO:0007165 | 0.00000 | 1.54538 | 285 | 369 | 6155 | signal transduction |
| GO:0045321 | 0.00000 | 1.99424 | 59 | 107 | 1284 | leukocyte activation |
| GO:0050727 | 0.00000 | 2.68408 | 22 | 54 | 485 | regulation of inflammatory response |
| GO:0006935 | 0.00000 | 2.41729 | 30 | 65 | 644 | chemotaxis |
| GO:0042330 | 0.00000 | 2.40869 | 30 | 65 | 646 | taxis |
| GO:0001501 | 0.00000 | 2.59849 | 24 | 56 | 518 | skeletal system development |
| GO:0030155 | 0.00000 | 2.35308 | 32 | 68 | 691 | regulation of cell adhesion |
| GO:0051179 | 0.00000 | 1.49025 | 312 | 391 | 6735 | localization |
| GO:0043269 | 0.00000 | 2.28140 | 32 | 67 | 699 | regulation of ion transport |
| GO:0070661 | 0.00000 | 3.10069 | 14 | 38 | 298 | leukocyte proliferation |
| GO:0045055 | 0.00000 | 2.18400 | 37 | 73 | 794 | regulated exocytosis |
| GO:0006812 | 0.00000 | 1.96420 | 54 | 96 | 1160 | cation transport |
| GO:0065008 | 0.00000 | 1.54873 | 188 | 256 | 4057 | regulation of biological quality |
| GO:0002366 | 0.00000 | 2.25183 | 33 | 67 | 707 | leukocyte activation involved in immune response |
| GO:0002263 | 0.00000 | 2.23732 | 33 | 67 | 711 | cell activation involved in immune response |
| GO:0002682 | 0.00000 | 1.79171 | 77 | 125 | 1659 | regulation of immune system process |
| GO:0006955 | 0.00000 | 1.68001 | 106 | 160 | 2279 | immune response |
| GO:0051046 | 0.00000 | 2.13156 | 38 | 73 | 811 | regulation of secretion |
| GO:0022407 | 0.00000 | 2.67446 | 19 | 45 | 403 | regulation of cell-cell adhesion |
| GO:0065007 | 0.00000 | 1.53162 | 592 | 662 | 12777 | biological regulation |
| GO:0009611 | 0.00000 | 2.23707 | 31 | 64 | 678 | response to wounding |
| GO:0000280 | 0.00000 | 2.64430 | 19 | 45 | 407 | nuclear division |
| GO:0006887 | 0.00000 | 2.03988 | 42 | 78 | 903 | exocytosis |
| GO:0008284 | 0.00000 | 2.01111 | 44 | 81 | 951 | positive regulation of cell proliferation |
| GO:1903530 | 0.00000 | 2.13238 | 35 | 68 | 753 | regulation of secretion by cell |
| GO:0006810 | 0.00000 | 1.47154 | 240 | 309 | 5190 | transport |
| GO:0031214 | 0.00000 | 3.81017 | 8 | 25 | 163 | biomineral tissue development |
| GO:0007159 | 0.00000 | 2.77383 | 16 | 39 | 337 | leukocyte cell-cell adhesion |
| GO:0046651 | 0.00000 | 3.01994 | 13 | 34 | 272 | lymphocyte proliferation |
| GO:0051050 | 0.00000 | 1.96709 | 45 | 82 | 982 | positive regulation of transport |
| GO:0051241 | 0.00000 | 1.82696 | 61 | 102 | 1316 | negative regulation of multicellular organismal process |
| GO:0042110 | 0.00000 | 2.45584 | 21 | 48 | 464 | T cell activation |
| GO:0032943 | 0.00000 | 2.99443 | 13 | 34 | 274 | mononuclear cell proliferation |
| GO:0015850 | 0.00000 | 3.04421 | 12 | 33 | 262 | organic hydroxy compound transport |
| GO:0051234 | 0.00000 | 1.45904 | 246 | 314 | 5315 | establishment of localization |
| GO:0051301 | 0.00000 | 2.25117 | 28 | 57 | 598 | cell division |
| GO:0050793 | 0.00000 | 1.58488 | 125 | 179 | 2696 | regulation of developmental process |
| GO:0140014 | 0.00000 | 3.01751 | 12 | 33 | 264 | mitotic nuclear division |
| GO:0010033 | 0.00000 | 1.53581 | 153 | 211 | 3302 | response to organic substance |
| GO:0048584 | 0.00000 | 1.59927 | 116 | 168 | 2500 | positive regulation of response to stimulus |
| GO:0050900 | 0.00000 | 2.37146 | 23 | 50 | 499 | leukocyte migration |
| GO:0002274 | 0.00000 | 2.17095 | 30 | 60 | 651 | myeloid leukocyte activation |
| GO:0042108 | 0.00000 | 6.02477 | 3 | 15 | 67 | positive regulation of cytokine biosynthetic process |
| GO:1903039 | 0.00000 | 3.23323 | 10 | 29 | 218 | positive regulation of leukocyte cell-cell adhesion |
| GO:0002526 | 0.00000 | 3.19902 | 10 | 29 | 220 | acute inflammatory response |
| GO:0050794 | 0.00000 | 1.43501 | 511 | 580 | 11022 | regulation of cellular process |
| GO:0048518 | 0.00000 | 1.42624 | 290 | 358 | 6254 | positive regulation of biological process |
| GO:0009888 | 0.00000 | 1.63673 | 96 | 143 | 2065 | tissue development |
| GO:0007399 | 0.00000 | 1.59736 | 110 | 160 | 2375 | nervous system development |
| GO:2000026 | 0.00000 | 1.62297 | 100 | 148 | 2157 | regulation of multicellular organismal development |
| GO:0003008 | 0.00000 | 1.61199 | 103 | 151 | 2216 | system process |
| GO:0051270 | 0.00000 | 1.85951 | 51 | 87 | 1097 | regulation of cellular component movement |
| GO:0030595 | 0.00000 | 3.13268 | 10 | 29 | 224 | leukocyte chemotaxis |
| GO:0045086 | 0.00000 | 24.20221 | 1 | 7 | 13 | positive regulation of interleukin-2 biosynthetic process |
| GO:0051783 | 0.00000 | 3.37496 | 9 | 26 | 188 | regulation of nuclear division |
| GO:0001649 | 0.00000 | 3.11652 | 10 | 29 | 225 | osteoblast differentiation |
| GO:0022617 | 0.00000 | 5.22409 | 4 | 16 | 80 | extracellular matrix disassembly |
| GO:0050789 | 0.00000 | 1.44770 | 560 | 626 | 12093 | regulation of biological process |
| GO:0051047 | 0.00000 | 2.43137 | 20 | 44 | 428 | positive regulation of secretion |
| GO:1903037 | 0.00000 | 2.74896 | 14 | 35 | 304 | regulation of leukocyte cell-cell adhesion |
| GO:0050870 | 0.00000 | 3.24589 | 9 | 27 | 202 | positive regulation of T cell activation |
| GO:0042060 | 0.00000 | 2.20899 | 26 | 53 | 564 | wound healing |
| GO:0022409 | 0.00000 | 2.91737 | 12 | 31 | 255 | positive regulation of cell-cell adhesion |
| GO:0051094 | 0.00000 | 1.73534 | 66 | 105 | 1418 | positive regulation of developmental process |
| GO:2000145 | 0.00000 | 1.87257 | 47 | 81 | 1012 | regulation of cell motility |
| GO:0010646 | 0.00000 | 1.48704 | 164 | 220 | 3542 | regulation of cell communication |
| GO:0048285 | 0.00000 | 2.36370 | 21 | 45 | 449 | organelle fission |
| GO:0042107 | 0.00000 | 4.02845 | 6 | 20 | 124 | cytokine metabolic process |
| GO:0050865 | 0.00000 | 2.13953 | 28 | 56 | 614 | regulation of cell activation |
| GO:0071310 | 0.00000 | 1.54154 | 125 | 176 | 2707 | cellular response to organic substance |
| GO:0050808 | 0.00000 | 2.43159 | 19 | 42 | 408 | synapse organization |
| GO:0040012 | 0.00000 | 1.83326 | 50 | 85 | 1084 | regulation of locomotion |
| GO:0001816 | 0.00000 | 1.98368 | 37 | 67 | 790 | cytokine production |
| GO:0050670 | 0.00000 | 3.13722 | 10 | 27 | 208 | regulation of lymphocyte proliferation |
| GO:0001568 | 0.00000 | 1.99728 | 35 | 65 | 761 | blood vessel development |
| GO:0032944 | 0.00000 | 3.11981 | 10 | 27 | 209 | regulation of mononuclear cell proliferation |
| GO:0002791 | 0.00000 | 2.25556 | 23 | 48 | 500 | regulation of peptide secretion |
| GO:0042116 | 0.00000 | 4.55610 | 4 | 17 | 95 | macrophage activation |
| GO:0006950 | 0.00000 | 1.45114 | 190 | 248 | 4110 | response to stress |
| GO:1903532 | 0.00000 | 2.42490 | 18 | 41 | 399 | positive regulation of secretion by cell |
| GO:0050708 | 0.00000 | 2.29134 | 22 | 46 | 472 | regulation of protein secretion |
| GO:0019221 | 0.00000 | 1.96106 | 37 | 67 | 798 | cytokine-mediated signaling pathway |
| GO:0002684 | 0.00000 | 1.77216 | 55 | 90 | 1185 | positive regulation of immune system process |
| GO:0030334 | 0.00000 | 1.86598 | 44 | 76 | 950 | regulation of cell migration |
| GO:0002694 | 0.00000 | 2.13030 | 26 | 52 | 571 | regulation of leukocyte activation |
| GO:0001944 | 0.00000 | 1.94322 | 37 | 66 | 792 | vasculature development |
| GO:0023051 | 0.00000 | 1.46046 | 166 | 220 | 3591 | regulation of signaling |
| GO:0048514 | 0.00000 | 2.02221 | 32 | 59 | 681 | blood vessel morphogenesis |
| GO:0042129 | 0.00000 | 3.44153 | 7 | 22 | 156 | regulation of T cell proliferation |
| GO:0046649 | 0.00000 | 1.97157 | 34 | 62 | 733 | lymphocyte activation |
| GO:0002521 | 0.00000 | 2.18123 | 24 | 48 | 515 | leukocyte differentiation |
| GO:0034220 | 0.00000 | 1.75362 | 55 | 89 | 1182 | ion transmembrane transport |
| GO:0098883 | 0.00000 | 24.86612 | 1 | 6 | 11 | synapse pruning |
| GO:0042089 | 0.00000 | 3.82250 | 6 | 19 | 123 | cytokine biosynthetic process |
| GO:0050863 | 0.00000 | 2.56081 | 15 | 34 | 314 | regulation of T cell activation |
| GO:0072358 | 0.00000 | 1.91842 | 37 | 66 | 801 | cardiovascular system development |
| GO:0072359 | 0.00000 | 1.75217 | 54 | 88 | 1169 | circulatory system development |
| GO:0043299 | 0.00000 | 2.14443 | 25 | 49 | 534 | leukocyte degranulation |
| GO:0031347 | 0.00000 | 1.85926 | 42 | 72 | 901 | regulation of defense response |
| GO:0070663 | 0.00000 | 2.90968 | 10 | 27 | 222 | regulation of leukocyte proliferation |
| GO:0042098 | 0.00000 | 3.14715 | 9 | 24 | 184 | T cell proliferation |
| GO:0042035 | 0.00000 | 3.92023 | 5 | 18 | 114 | regulation of cytokine biosynthetic process |
| GO:0060326 | 0.00001 | 2.56627 | 14 | 33 | 304 | cell chemotaxis |
| GO:0035295 | 0.00001 | 1.75892 | 51 | 84 | 1110 | tube development |
| GO:0002252 | 0.00001 | 1.70966 | 59 | 93 | 1265 | immune effector process |
| GO:0001525 | 0.00001 | 2.06467 | 27 | 52 | 587 | angiogenesis |
| GO:1901700 | 0.00001 | 1.62283 | 76 | 114 | 1637 | response to oxygen-containing compound |
| GO:0098657 | 0.00001 | 1.81885 | 44 | 74 | 945 | import into cell |
| GO:0050776 | 0.00001 | 1.74987 | 52 | 84 | 1115 | regulation of immune response |
| GO:0042102 | 0.00001 | 4.22859 | 4 | 16 | 95 | positive regulation of T cell proliferation |
| GO:0002275 | 0.00001 | 2.09990 | 25 | 49 | 544 | myeloid cell activation involved in immune response |
| GO:0009306 | 0.00001 | 2.04888 | 27 | 52 | 591 | protein secretion |
| GO:0071345 | 0.00001 | 1.74448 | 52 | 84 | 1118 | cellular response to cytokine stimulus |
| GO:0030574 | 0.00001 | 6.35763 | 2 | 11 | 47 | collagen catabolic process |
| GO:0001817 | 0.00001 | 1.93925 | 33 | 60 | 719 | regulation of cytokine production |
| GO:0002790 | 0.00001 | 2.01330 | 29 | 54 | 624 | peptide secretion |
| GO:0035239 | 0.00001 | 1.81557 | 43 | 72 | 920 | tube morphogenesis |
| GO:0034097 | 0.00001 | 1.70533 | 56 | 89 | 1211 | response to cytokine |
| GO:0050764 | 0.00001 | 4.07320 | 5 | 16 | 98 | regulation of phagocytosis |
| GO:0008217 | 0.00001 | 3.03155 | 8 | 23 | 182 | regulation of blood pressure |
| GO:0001819 | 0.00001 | 2.16005 | 21 | 43 | 464 | positive regulation of cytokine production |
| GO:0045076 | 0.00001 | 12.09703 | 1 | 7 | 19 | regulation of interleukin-2 biosynthetic process |
| GO:0009887 | 0.00001 | 1.73465 | 49 | 80 | 1068 | animal organ morphogenesis |
| GO:0048699 | 0.00001 | 1.61394 | 71 | 106 | 1524 | generation of neurons |
| GO:0002673 | 0.00001 | 3.18538 | 7 | 21 | 159 | regulation of acute inflammatory response |
| GO:0097529 | 0.00001 | 2.83462 | 10 | 25 | 210 | myeloid leukocyte migration |
| GO:0015844 | 0.00002 | 4.17176 | 4 | 15 | 90 | monoamine transport |
| GO:0010038 | 0.00002 | 2.31388 | 17 | 36 | 364 | response to metal ion |
| GO:0007059 | 0.00002 | 2.41245 | 15 | 33 | 321 | chromosome segregation |
| GO:0050867 | 0.00002 | 2.25216 | 18 | 38 | 394 | positive regulation of cell activation |
| GO:0002696 | 0.00002 | 2.27495 | 18 | 37 | 380 | positive regulation of leukocyte activation |
| GO:0022008 | 0.00002 | 1.58636 | 75 | 111 | 1623 | neurogenesis |
| GO:0032103 | 0.00002 | 2.39554 | 15 | 33 | 323 | positive regulation of response to external stimulus |
| GO:0030282 | 0.00002 | 3.65975 | 5 | 17 | 114 | bone mineralization |
| GO:0002444 | 0.00002 | 2.02091 | 26 | 48 | 551 | myeloid leukocyte mediated immunity |
| GO:0015872 | 0.00002 | 5.58074 | 2 | 11 | 52 | dopamine transport |
| GO:0016192 | 0.00002 | 1.51266 | 98 | 137 | 2107 | vesicle-mediated transport |
| GO:0032963 | 0.00002 | 3.62220 | 5 | 17 | 115 | collagen metabolic process |
| GO:0090087 | 0.00002 | 1.87209 | 34 | 59 | 729 | regulation of peptide transport |
| GO:0048468 | 0.00002 | 1.50336 | 101 | 141 | 2183 | cell development |
| GO:0007088 | 0.00002 | 3.07313 | 8 | 21 | 164 | regulation of mitotic nuclear division |
| GO:0051223 | 0.00002 | 1.88591 | 32 | 57 | 699 | regulation of protein transport |
| GO:0044331 | 0.00003 | 6.11318 | 2 | 10 | 44 | cell-cell adhesion mediated by cadherin |
| GO:0099536 | 0.00003 | 1.86996 | 33 | 58 | 717 | synaptic signaling |
| GO:0002683 | 0.00003 | 2.10725 | 21 | 42 | 463 | negative regulation of immune system process |
| GO:0007601 | 0.00003 | 2.71589 | 10 | 25 | 218 | visual perception |
| GO:0045595 | 0.00003 | 1.53136 | 87 | 124 | 1878 | regulation of cell differentiation |
| GO:0007268 | 0.00003 | 1.87380 | 33 | 57 | 703 | chemical synaptic transmission |
| GO:0098916 | 0.00003 | 1.87380 | 33 | 57 | 703 | anterograde trans-synaptic signaling |
| GO:0030199 | 0.00003 | 5.32057 | 3 | 11 | 54 | collagen fibril organization |
| GO:0032663 | 0.00003 | 5.32057 | 3 | 11 | 54 | regulation of interleukin-2 production |
| GO:0015696 | 0.00004 | 3.62841 | 5 | 16 | 108 | ammonium transport |
| GO:0050878 | 0.00004 | 2.03443 | 23 | 44 | 501 | regulation of body fluid levels |
| GO:0042476 | 0.00004 | 3.29789 | 6 | 18 | 132 | odontogenesis |
| GO:0050953 | 0.00004 | 2.66014 | 10 | 25 | 222 | sensory perception of light stimulus |
| GO:0006468 | 0.00004 | 1.50796 | 92 | 129 | 1983 | protein phosphorylation |
| GO:0099537 | 0.00004 | 1.85001 | 33 | 57 | 711 | trans-synaptic signaling |
| GO:0032102 | 0.00004 | 2.23302 | 17 | 35 | 365 | negative regulation of response to external stimulus |
| GO:0042094 | 0.00004 | 9.67599 | 1 | 7 | 22 | interleukin-2 biosynthetic process |
| GO:0050707 | 0.00004 | 2.70323 | 10 | 24 | 210 | regulation of cytokine secretion |
| GO:0036230 | 0.00004 | 2.02081 | 23 | 44 | 504 | granulocyte activation |
| GO:0051785 | 0.00004 | 4.62446 | 3 | 12 | 66 | positive regulation of nuclear division |
| GO:2000241 | 0.00005 | 3.12617 | 7 | 19 | 146 | regulation of reproductive process |
| GO:0051048 | 0.00005 | 2.57167 | 11 | 26 | 238 | negative regulation of secretion |
| GO:1903531 | 0.00005 | 2.68863 | 10 | 24 | 211 | negative regulation of secretion by cell |
| GO:0048523 | 0.00005 | 1.34962 | 227 | 278 | 4903 | negative regulation of cellular process |
| GO:0030001 | 0.00005 | 1.74803 | 41 | 67 | 883 | metal ion transport |
| GO:0050921 | 0.00005 | 3.21279 | 6 | 18 | 135 | positive regulation of chemotaxis |
| GO:0051592 | 0.00006 | 3.07735 | 7 | 19 | 148 | response to calcium ion |
| GO:0001774 | 0.00006 | 5.46845 | 2 | 10 | 48 | microglial cell activation |
| GO:0002269 | 0.00006 | 5.46845 | 2 | 10 | 48 | leukocyte activation involved in inflammatory response |
| GO:0090068 | 0.00006 | 2.35101 | 14 | 30 | 298 | positive regulation of cell cycle process |
| GO:0045785 | 0.00006 | 2.12918 | 19 | 37 | 403 | positive regulation of cell adhesion |
| GO:0050877 | 0.00007 | 1.57122 | 67 | 98 | 1437 | nervous system process |
| GO:1903555 | 0.00007 | 2.92333 | 8 | 20 | 163 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0051897 | 0.00007 | 2.83328 | 8 | 21 | 176 | positive regulation of protein kinase B signaling |
| GO:0042119 | 0.00007 | 1.99473 | 23 | 43 | 498 | neutrophil activation |
| GO:0014046 | 0.00007 | 6.02826 | 2 | 9 | 40 | dopamine secretion |
| GO:0014059 | 0.00007 | 6.02826 | 2 | 9 | 40 | regulation of dopamine secretion |
| GO:0048646 | 0.00007 | 1.62761 | 54 | 83 | 1173 | anatomical structure formation involved in morphogenesis |
| GO:0050920 | 0.00007 | 2.60415 | 10 | 24 | 217 | regulation of chemotaxis |
| GO:0000902 | 0.00007 | 1.66768 | 48 | 75 | 1034 | cell morphogenesis |
| GO:1902563 | 0.00008 | 17.24709 | 1 | 5 | 11 | regulation of neutrophil activation |
| GO:0043312 | 0.00008 | 2.00007 | 22 | 42 | 485 | neutrophil degranulation |
| GO:0010562 | 0.00008 | 1.63211 | 53 | 81 | 1141 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00008 | 1.63211 | 53 | 81 | 1141 | positive regulation of phosphate metabolic process |
| GO:0080134 | 0.00008 | 1.52712 | 76 | 109 | 1645 | regulation of response to stress |
| GO:0050729 | 0.00009 | 2.96169 | 7 | 19 | 153 | positive regulation of inflammatory response |
| GO:0002283 | 0.00009 | 1.98627 | 23 | 42 | 488 | neutrophil activation involved in immune response |
| GO:0098813 | 0.00009 | 2.40893 | 12 | 27 | 262 | nuclear chromosome segregation |
| GO:0050709 | 0.00009 | 3.05503 | 7 | 18 | 141 | negative regulation of protein secretion |
| GO:0009410 | 0.00010 | 2.31374 | 14 | 29 | 292 | response to xenobiotic stimulus |
| GO:0030097 | 0.00010 | 1.70881 | 41 | 66 | 887 | hemopoiesis |
| GO:0002238 | 0.00010 | Inf | 0 | 3 | 3 | response to molecule of fungal origin |
| GO:0071226 | 0.00010 | Inf | 0 | 3 | 3 | cellular response to molecule of fungal origin |
| GO:0071706 | 0.00010 | 2.82376 | 8 | 20 | 168 | tumor necrosis factor superfamily cytokine production |
| GO:0048522 | 0.00011 | 1.31857 | 254 | 304 | 5490 | positive regulation of cellular process |
| GO:0002286 | 0.00011 | 3.43516 | 5 | 15 | 106 | T cell activation involved in immune response |
| GO:0051216 | 0.00011 | 2.58752 | 10 | 23 | 209 | cartilage development |
| GO:0002443 | 0.00011 | 1.70695 | 40 | 65 | 874 | leukocyte mediated immunity |
| GO:0002685 | 0.00012 | 2.64437 | 9 | 22 | 196 | regulation of leukocyte migration |
| GO:0032623 | 0.00012 | 4.48395 | 3 | 11 | 62 | interleukin-2 production |
| GO:0032945 | 0.00012 | 4.09217 | 3 | 12 | 73 | negative regulation of mononuclear cell proliferation |
| GO:0050672 | 0.00012 | 4.09217 | 3 | 12 | 73 | negative regulation of lymphocyte proliferation |
| GO:0002921 | 0.00013 | 14.78239 | 1 | 5 | 12 | negative regulation of humoral immune response |
| GO:0015816 | 0.00013 | 14.78239 | 1 | 5 | 12 | glycine transport |
| GO:0008285 | 0.00013 | 1.75101 | 35 | 58 | 760 | negative regulation of cell proliferation |
| GO:0050663 | 0.00014 | 2.43494 | 11 | 25 | 240 | cytokine secretion |
| GO:0043410 | 0.00014 | 1.89543 | 25 | 45 | 546 | positive regulation of MAPK cascade |
| GO:0001915 | 0.00014 | 27.56794 | 0 | 4 | 7 | negative regulation of T cell mediated cytotoxicity |
| GO:0044691 | 0.00014 | 27.56794 | 0 | 4 | 7 | tooth eruption |
| GO:0042493 | 0.00014 | 1.63896 | 47 | 73 | 1021 | response to drug |
| GO:0002446 | 0.00014 | 1.93724 | 23 | 42 | 499 | neutrophil mediated immunity |
| GO:0070201 | 0.00015 | 1.75245 | 35 | 57 | 746 | regulation of establishment of protein localization |
| GO:0015893 | 0.00016 | 2.51907 | 10 | 23 | 214 | drug transport |
| GO:0051249 | 0.00016 | 1.94558 | 22 | 41 | 485 | regulation of lymphocyte activation |
| GO:0032680 | 0.00016 | 2.81354 | 7 | 19 | 160 | regulation of tumor necrosis factor production |
| GO:0048812 | 0.00016 | 1.80593 | 30 | 51 | 648 | neuron projection morphogenesis |
| GO:0150076 | 0.00016 | 3.96182 | 3 | 12 | 75 | neuroinflammatory response |
| GO:0048585 | 0.00016 | 1.49303 | 78 | 110 | 1693 | negative regulation of response to stimulus |
| GO:0010647 | 0.00017 | 1.47157 | 85 | 118 | 1844 | positive regulation of cell communication |
| GO:0002792 | 0.00017 | 2.88938 | 7 | 18 | 148 | negative regulation of peptide secretion |
| GO:0098660 | 0.00017 | 1.69893 | 39 | 62 | 836 | inorganic ion transmembrane transport |
| GO:0051781 | 0.00018 | 3.65599 | 4 | 13 | 87 | positive regulation of cell division |
| GO:0009966 | 0.00018 | 1.37046 | 147 | 187 | 3170 | regulation of signal transduction |
| GO:0061448 | 0.00018 | 2.29977 | 13 | 27 | 273 | connective tissue development |
| GO:0035987 | 0.00019 | 5.18954 | 2 | 9 | 45 | endodermal cell differentiation |
| GO:0000819 | 0.00019 | 2.61211 | 9 | 21 | 189 | sister chromatid segregation |
| GO:0030278 | 0.00019 | 2.54110 | 9 | 22 | 203 | regulation of ossification |
| GO:0060348 | 0.00019 | 2.47969 | 10 | 23 | 217 | bone development |
| GO:0042554 | 0.00020 | 5.92665 | 2 | 8 | 36 | superoxide anion generation |
| GO:0007043 | 0.00020 | 3.08808 | 6 | 16 | 124 | cell-cell junction assembly |
| GO:0023056 | 0.00020 | 1.46498 | 86 | 118 | 1851 | positive regulation of signaling |
| GO:0070208 | 0.00020 | 12.93387 | 1 | 5 | 13 | protein heterotrimerization |
| GO:0032640 | 0.00020 | 2.75446 | 8 | 19 | 163 | tumor necrosis factor production |
| GO:0071248 | 0.00020 | 2.59651 | 9 | 21 | 190 | cellular response to metal ion |
| GO:0051937 | 0.00021 | 3.83948 | 4 | 12 | 77 | catecholamine transport |
| GO:0007416 | 0.00021 | 2.66054 | 8 | 20 | 177 | synapse assembly |
| GO:0048534 | 0.00021 | 1.65027 | 43 | 67 | 929 | hematopoietic or lymphoid organ development |
| GO:0001934 | 0.00022 | 1.61989 | 47 | 72 | 1017 | positive regulation of protein phosphorylation |
| GO:0007596 | 0.00022 | 2.13272 | 16 | 31 | 336 | blood coagulation |
| GO:0009636 | 0.00022 | 1.88006 | 24 | 43 | 525 | response to toxic substance |
| GO:0000070 | 0.00022 | 2.82373 | 7 | 18 | 151 | mitotic sister chromatid segregation |
| GO:0007193 | 0.00022 | 3.55938 | 4 | 13 | 89 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| GO:0032602 | 0.00022 | 3.55938 | 4 | 13 | 89 | chemokine production |
| GO:0032989 | 0.00023 | 1.58141 | 53 | 79 | 1143 | cellular component morphogenesis |
| GO:0070664 | 0.00023 | 3.78109 | 4 | 12 | 78 | negative regulation of leukocyte proliferation |
| GO:0045667 | 0.00024 | 3.03159 | 6 | 16 | 126 | regulation of osteoblast differentiation |
| GO:0051246 | 0.00025 | 1.37146 | 136 | 174 | 2936 | regulation of protein metabolic process |
| GO:0010035 | 0.00026 | 1.83507 | 26 | 45 | 562 | response to inorganic substance |
| GO:0030193 | 0.00027 | 3.72445 | 4 | 12 | 79 | regulation of blood coagulation |
| GO:0120039 | 0.00027 | 1.76312 | 31 | 51 | 662 | plasma membrane bounded cell projection morphogenesis |
| GO:0006820 | 0.00027 | 1.78335 | 29 | 49 | 629 | anion transport |
| GO:0061564 | 0.00027 | 1.87405 | 24 | 42 | 514 | axon development |
| GO:0043313 | 0.00028 | 20.67480 | 0 | 4 | 8 | regulation of neutrophil degranulation |
| GO:0044771 | 0.00028 | 20.67480 | 0 | 4 | 8 | meiotic cell cycle phase transition |
| GO:0045916 | 0.00028 | 20.67480 | 0 | 4 | 8 | negative regulation of complement activation |
| GO:1901993 | 0.00028 | 20.67480 | 0 | 4 | 8 | regulation of meiotic cell cycle phase transition |
| GO:2000258 | 0.00028 | 20.67480 | 0 | 4 | 8 | negative regulation of protein activation cascade |
| GO:0045597 | 0.00028 | 1.61416 | 46 | 70 | 991 | positive regulation of cell differentiation |
| GO:0007599 | 0.00028 | 2.09772 | 16 | 31 | 341 | hemostasis |
| GO:0007167 | 0.00029 | 1.59622 | 48 | 73 | 1045 | enzyme linked receptor protein signaling pathway |
| GO:0071229 | 0.00029 | 2.45873 | 10 | 22 | 209 | cellular response to acid chemical |
| GO:0060627 | 0.00029 | 1.85240 | 25 | 43 | 532 | regulation of vesicle-mediated transport |
| GO:0050817 | 0.00030 | 2.09086 | 16 | 31 | 342 | coagulation |
| GO:0072216 | 0.00030 | 11.49612 | 1 | 5 | 14 | positive regulation of metanephros development |
| GO:0051302 | 0.00030 | 2.66127 | 8 | 19 | 168 | regulation of cell division |
| GO:0032722 | 0.00030 | 4.32675 | 3 | 10 | 58 | positive regulation of chemokine production |
| GO:0061900 | 0.00030 | 4.32675 | 3 | 10 | 58 | glial cell activation |
| GO:1900046 | 0.00030 | 3.66947 | 4 | 12 | 80 | regulation of hemostasis |
| GO:0000165 | 0.00030 | 1.62156 | 44 | 68 | 958 | MAPK cascade |
| GO:0007409 | 0.00030 | 1.91239 | 22 | 39 | 468 | axonogenesis |
| GO:1901701 | 0.00031 | 1.56881 | 53 | 78 | 1136 | cellular response to oxygen-containing compound |
| GO:0048858 | 0.00031 | 1.75124 | 31 | 51 | 666 | cell projection morphogenesis |
| GO:0043408 | 0.00031 | 1.69605 | 36 | 57 | 768 | regulation of MAPK cascade |
| GO:0001101 | 0.00031 | 2.08404 | 16 | 31 | 343 | response to acid chemical |
| GO:0006897 | 0.00031 | 1.67162 | 38 | 60 | 820 | endocytosis |
| GO:0031175 | 0.00032 | 1.61122 | 45 | 69 | 978 | neuron projection development |
| GO:0001932 | 0.00032 | 1.49878 | 68 | 96 | 1465 | regulation of protein phosphorylation |
| GO:0003013 | 0.00032 | 1.82851 | 26 | 44 | 551 | circulatory system process |
| GO:0045216 | 0.00033 | 2.72065 | 7 | 18 | 156 | cell-cell junction organization |
| GO:0006836 | 0.00033 | 2.23964 | 12 | 26 | 269 | neurotransmitter transport |
| GO:0050671 | 0.00034 | 2.92456 | 6 | 16 | 130 | positive regulation of lymphocyte proliferation |
| GO:0033273 | 0.00035 | 3.38065 | 4 | 13 | 93 | response to vitamin |
| GO:0035249 | 0.00035 | 3.38065 | 4 | 13 | 93 | synaptic transmission, glutamatergic |
| GO:0051966 | 0.00035 | 3.87421 | 3 | 11 | 70 | regulation of synaptic transmission, glutamatergic |
| GO:2000648 | 0.00035 | 5.35220 | 2 | 8 | 39 | positive regulation of stem cell proliferation |
| GO:0032743 | 0.00036 | 6.30759 | 1 | 7 | 30 | positive regulation of interleukin-2 production |
| GO:0051445 | 0.00036 | 4.66954 | 2 | 9 | 49 | regulation of meiotic cell cycle |
| GO:0032946 | 0.00037 | 2.89896 | 6 | 16 | 131 | positive regulation of mononuclear cell proliferation |
| GO:0032642 | 0.00038 | 3.56423 | 4 | 12 | 82 | regulation of chemokine production |
| GO:0050866 | 0.00038 | 2.46397 | 9 | 21 | 199 | negative regulation of cell activation |
| GO:0009608 | 0.00038 | 61.96288 | 0 | 3 | 4 | response to symbiont |
| GO:0009609 | 0.00038 | 61.96288 | 0 | 3 | 4 | response to symbiotic bacterium |
| GO:0043315 | 0.00038 | 61.96288 | 0 | 3 | 4 | positive regulation of neutrophil degranulation |
| GO:0060244 | 0.00038 | 61.96288 | 0 | 3 | 4 | negative regulation of cell proliferation involved in contact inhibition |
| GO:0150062 | 0.00038 | 61.96288 | 0 | 3 | 4 | complement-mediated synapse pruning |
| GO:1902565 | 0.00038 | 61.96288 | 0 | 3 | 4 | positive regulation of neutrophil activation |
| GO:1903224 | 0.00038 | 61.96288 | 0 | 3 | 4 | regulation of endodermal cell differentiation |
| GO:1901216 | 0.00039 | 3.33872 | 4 | 13 | 94 | positive regulation of neuron death |
| GO:0002520 | 0.00039 | 1.59825 | 46 | 69 | 985 | immune system development |
| GO:0023014 | 0.00041 | 1.60072 | 45 | 68 | 969 | signal transduction by protein phosphorylation |
| GO:0008015 | 0.00042 | 1.81798 | 25 | 43 | 541 | blood circulation |
| GO:0098742 | 0.00042 | 2.20287 | 13 | 26 | 273 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0001706 | 0.00043 | 4.55539 | 2 | 9 | 50 | endoderm formation |
| GO:0030336 | 0.00043 | 2.06835 | 15 | 30 | 334 | negative regulation of cell migration |
| GO:0051251 | 0.00043 | 2.06835 | 15 | 30 | 334 | positive regulation of lymphocyte activation |
| GO:0003014 | 0.00044 | 2.97479 | 6 | 15 | 120 | renal system process |
| GO:0007204 | 0.00044 | 2.09510 | 15 | 29 | 319 | positive regulation of cytosolic calcium ion concentration |
| GO:0002675 | 0.00044 | 6.04443 | 1 | 7 | 31 | positive regulation of acute inflammatory response |
| GO:0007162 | 0.00044 | 2.15736 | 13 | 27 | 289 | negative regulation of cell adhesion |
| GO:0032526 | 0.00046 | 3.09966 | 5 | 14 | 108 | response to retinoic acid |
| GO:1903046 | 0.00047 | 2.48478 | 9 | 20 | 188 | meiotic cell cycle process |
| GO:0050818 | 0.00047 | 3.46483 | 4 | 12 | 84 | regulation of coagulation |
| GO:0032755 | 0.00048 | 3.25790 | 4 | 13 | 96 | positive regulation of interleukin-6 production |
| GO:0046718 | 0.00048 | 2.94656 | 6 | 15 | 121 | viral entry into host cell |
| GO:0030260 | 0.00048 | 2.82478 | 6 | 16 | 134 | entry into host cell |
| GO:0044409 | 0.00048 | 2.82478 | 6 | 16 | 134 | entry into host |
| GO:0051806 | 0.00048 | 2.82478 | 6 | 16 | 134 | entry into cell of other organism involved in symbiotic interaction |
| GO:0051828 | 0.00048 | 2.82478 | 6 | 16 | 134 | entry into other organism involved in symbiotic interaction |
| GO:0051271 | 0.00050 | 1.97232 | 18 | 33 | 384 | negative regulation of cellular component movement |
| GO:0022414 | 0.00050 | 1.48500 | 66 | 93 | 1429 | reproductive process |
| GO:0050433 | 0.00052 | 3.99303 | 3 | 10 | 62 | regulation of catecholamine secretion |
| GO:0031960 | 0.00053 | 2.60640 | 8 | 18 | 162 | response to corticosteroid |
| GO:0055085 | 0.00053 | 1.45738 | 74 | 102 | 1598 | transmembrane transport |
| GO:0002573 | 0.00053 | 2.39597 | 9 | 21 | 204 | myeloid leukocyte differentiation |
| GO:0098655 | 0.00053 | 1.62549 | 40 | 61 | 855 | cation transmembrane transport |
| GO:0097305 | 0.00054 | 2.28868 | 11 | 23 | 233 | response to alcohol |
| GO:0000003 | 0.00054 | 1.48140 | 66 | 93 | 1432 | reproduction |
| GO:0042327 | 0.00054 | 1.55719 | 49 | 73 | 1068 | positive regulation of phosphorylation |
| GO:0040017 | 0.00054 | 1.75549 | 28 | 46 | 598 | positive regulation of locomotion |
| GO:0008608 | 0.00054 | 5.80233 | 1 | 7 | 32 | attachment of spindle microtubules to kinetochore |
| GO:0051247 | 0.00056 | 1.44002 | 79 | 108 | 1713 | positive regulation of protein metabolic process |
| GO:0032653 | 0.00058 | 4.34302 | 2 | 9 | 52 | regulation of interleukin-10 production |
| GO:0048667 | 0.00058 | 1.76130 | 27 | 45 | 583 | cell morphogenesis involved in neuron differentiation |
| GO:0051321 | 0.00058 | 2.22973 | 12 | 24 | 249 | meiotic cell cycle |
| GO:0031341 | 0.00058 | 3.18089 | 5 | 13 | 98 | regulation of cell killing |
| GO:0032990 | 0.00059 | 1.69688 | 32 | 51 | 685 | cell part morphogenesis |
| GO:0035418 | 0.00059 | 3.91747 | 3 | 10 | 63 | protein localization to synapse |
| GO:2000401 | 0.00059 | 3.91747 | 3 | 10 | 63 | regulation of lymphocyte migration |
| GO:0046777 | 0.00061 | 2.26683 | 11 | 23 | 235 | protein autophosphorylation |
| GO:2000147 | 0.00061 | 1.76745 | 26 | 44 | 568 | positive regulation of cell motility |
| GO:0007188 | 0.00063 | 2.30889 | 10 | 22 | 221 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:0048666 | 0.00063 | 1.53825 | 51 | 75 | 1110 | neuron development |
| GO:0001818 | 0.00064 | 2.10038 | 14 | 27 | 296 | negative regulation of cytokine production |
| GO:0030100 | 0.00065 | 2.13279 | 13 | 26 | 281 | regulation of endocytosis |
| GO:0046677 | 0.00065 | 2.03792 | 15 | 29 | 327 | response to antibiotic |
| GO:0050954 | 0.00066 | 2.55278 | 8 | 18 | 165 | sensory perception of mechanical stimulus |
| GO:0014070 | 0.00066 | 1.59181 | 42 | 64 | 915 | response to organic cyclic compound |
| GO:0014072 | 0.00066 | 5.57885 | 2 | 7 | 33 | response to isoquinoline alkaloid |
| GO:0043278 | 0.00066 | 5.57885 | 2 | 7 | 33 | response to morphine |
| GO:0006968 | 0.00067 | 4.24408 | 2 | 9 | 53 | cellular defense response |
| GO:0045840 | 0.00067 | 4.24408 | 2 | 9 | 53 | positive regulation of mitotic nuclear division |
| GO:0055074 | 0.00067 | 1.84349 | 22 | 38 | 471 | calcium ion homeostasis |
| GO:0045471 | 0.00067 | 2.83877 | 6 | 15 | 125 | response to ethanol |
| GO:0045669 | 0.00067 | 3.84470 | 3 | 10 | 64 | positive regulation of osteoblast differentiation |
| GO:0050432 | 0.00067 | 3.84470 | 3 | 10 | 64 | catecholamine secretion |
| GO:0098771 | 0.00068 | 1.65909 | 34 | 54 | 741 | inorganic ion homeostasis |
| GO:0001890 | 0.00069 | 2.62395 | 7 | 17 | 152 | placenta development |
| GO:0032675 | 0.00069 | 2.62395 | 7 | 17 | 152 | regulation of interleukin-6 production |
| GO:0007586 | 0.00072 | 2.70918 | 6 | 16 | 139 | digestion |
| GO:0050715 | 0.00072 | 2.70918 | 6 | 16 | 139 | positive regulation of cytokine secretion |
| GO:0070665 | 0.00072 | 2.70918 | 6 | 16 | 139 | positive regulation of leukocyte proliferation |
| GO:1903557 | 0.00073 | 3.28173 | 4 | 12 | 88 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0000904 | 0.00074 | 1.65158 | 34 | 54 | 744 | cell morphogenesis involved in differentiation |
| GO:0002285 | 0.00076 | 2.44591 | 8 | 19 | 181 | lymphocyte activation involved in immune response |
| GO:0001660 | 0.00077 | 13.78165 | 0 | 4 | 10 | fever generation |
| GO:1904645 | 0.00077 | 4.14953 | 3 | 9 | 54 | response to amyloid-beta |
| GO:0051093 | 0.00078 | 1.54354 | 48 | 71 | 1046 | negative regulation of developmental process |
| GO:0034501 | 0.00082 | 8.62064 | 1 | 5 | 17 | protein localization to kinetochore |
| GO:0007610 | 0.00085 | 1.72491 | 28 | 45 | 594 | behavior |
| GO:0040013 | 0.00085 | 1.90581 | 18 | 33 | 396 | negative regulation of locomotion |
| GO:0007187 | 0.00086 | 2.16159 | 12 | 24 | 256 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0032880 | 0.00086 | 1.54654 | 47 | 69 | 1014 | regulation of protein localization |
| GO:0030335 | 0.00086 | 1.75901 | 25 | 42 | 544 | positive regulation of cell migration |
| GO:0032613 | 0.00088 | 4.05910 | 3 | 9 | 55 | interleukin-10 production |
| GO:0043030 | 0.00088 | 4.05910 | 3 | 9 | 55 | regulation of macrophage activation |
| GO:2000146 | 0.00088 | 1.96940 | 16 | 30 | 349 | negative regulation of cell motility |
| GO:1902105 | 0.00090 | 2.11563 | 13 | 25 | 272 | regulation of leukocyte differentiation |
| GO:0046645 | 0.00092 | 30.97970 | 0 | 3 | 5 | positive regulation of gamma-delta T cell activation |
| GO:0060718 | 0.00092 | 30.97970 | 0 | 3 | 5 | chorionic trophoblast cell differentiation |
| GO:0061743 | 0.00092 | 30.97970 | 0 | 3 | 5 | motor learning |
| GO:1901995 | 0.00092 | 30.97970 | 0 | 3 | 5 | positive regulation of meiotic cell cycle phase transition |
| GO:0002793 | 0.00094 | 2.07498 | 13 | 26 | 288 | positive regulation of peptide secretion |
| GO:0072507 | 0.00094 | 1.77662 | 24 | 40 | 513 | divalent inorganic cation homeostasis |
| GO:0098662 | 0.00095 | 1.63189 | 35 | 54 | 752 | inorganic cation transmembrane transport |
| GO:0030182 | 0.00096 | 1.46586 | 63 | 88 | 1365 | neuron differentiation |
| GO:0002820 | 0.00096 | 4.48277 | 2 | 8 | 45 | negative regulation of adaptive immune response |
| GO:0016043 | 0.00097 | 1.25205 | 302 | 345 | 6512 | cellular component organization |
| GO:0002761 | 0.00103 | 2.82738 | 5 | 14 | 117 | regulation of myeloid leukocyte differentiation |
| GO:0140013 | 0.00107 | 2.43578 | 8 | 18 | 172 | meiotic nuclear division |
| GO:0006816 | 0.00108 | 1.83957 | 20 | 35 | 434 | calcium ion transport |
| GO:0001911 | 0.00109 | 7.95707 | 1 | 5 | 18 | negative regulation of leukocyte mediated cytotoxicity |
| GO:0071605 | 0.00109 | 7.95707 | 1 | 5 | 18 | monocyte chemotactic protein-1 production |
| GO:0071637 | 0.00109 | 7.95707 | 1 | 5 | 18 | regulation of monocyte chemotactic protein-1 production |
| GO:0055065 | 0.00110 | 1.67029 | 30 | 48 | 653 | metal ion homeostasis |
| GO:0051272 | 0.00112 | 1.71023 | 27 | 44 | 585 | positive regulation of cellular component movement |
| GO:0007605 | 0.00113 | 2.58230 | 7 | 16 | 145 | sensory perception of sound |
| GO:0097242 | 0.00115 | 5.00088 | 2 | 7 | 36 | amyloid-beta clearance |
| GO:0002923 | 0.00116 | 11.81218 | 1 | 4 | 11 | regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0035747 | 0.00116 | 11.81218 | 1 | 4 | 11 | natural killer cell chemotaxis |
| GO:0050804 | 0.00117 | 1.83018 | 20 | 35 | 436 | modulation of chemical synaptic transmission |
| GO:0045087 | 0.00117 | 1.53077 | 47 | 68 | 1008 | innate immune response |
| GO:0071241 | 0.00118 | 2.23540 | 10 | 21 | 217 | cellular response to inorganic substance |
| GO:0099177 | 0.00121 | 1.82553 | 20 | 35 | 437 | regulation of trans-synaptic signaling |
| GO:0050778 | 0.00122 | 1.55938 | 42 | 62 | 902 | positive regulation of immune response |
| GO:0071300 | 0.00123 | 3.51789 | 3 | 10 | 69 | cellular response to retinoic acid |
| GO:0001964 | 0.00125 | 5.91518 | 1 | 6 | 27 | startle response |
| GO:0051480 | 0.00126 | 1.92034 | 17 | 30 | 357 | regulation of cytosolic calcium ion concentration |
| GO:0002695 | 0.00130 | 2.38883 | 8 | 18 | 175 | negative regulation of leukocyte activation |
| GO:0045766 | 0.00131 | 2.26666 | 9 | 20 | 204 | positive regulation of angiogenesis |
| GO:0006029 | 0.00131 | 3.04057 | 4 | 12 | 94 | proteoglycan metabolic process |
| GO:0070167 | 0.00131 | 3.04057 | 4 | 12 | 94 | regulation of biomineral tissue development |
| GO:0032635 | 0.00132 | 2.45870 | 7 | 17 | 161 | interleukin-6 production |
| GO:0045730 | 0.00136 | 4.83392 | 2 | 7 | 37 | respiratory burst |
| GO:0055080 | 0.00140 | 1.61571 | 34 | 52 | 730 | cation homeostasis |
| GO:0061041 | 0.00141 | 2.52318 | 7 | 16 | 148 | regulation of wound healing |
| GO:0015669 | 0.00142 | 7.38829 | 1 | 5 | 19 | gas transport |
| GO:0032930 | 0.00142 | 7.38829 | 1 | 5 | 19 | positive regulation of superoxide anion generation |
| GO:0016485 | 0.00143 | 1.95197 | 15 | 28 | 328 | protein processing |
| GO:0051952 | 0.00144 | 3.00377 | 4 | 12 | 95 | regulation of amine transport |
| GO:1901698 | 0.00144 | 1.49878 | 50 | 72 | 1089 | response to nitrogen compound |
| GO:0002697 | 0.00144 | 1.78879 | 21 | 36 | 458 | regulation of immune effector process |
| GO:0009967 | 0.00145 | 1.40241 | 78 | 104 | 1685 | positive regulation of signal transduction |
| GO:0045931 | 0.00151 | 2.42475 | 8 | 17 | 163 | positive regulation of mitotic cell cycle |
| GO:0071277 | 0.00152 | 3.17238 | 4 | 11 | 83 | cellular response to calcium ion |
| GO:0001958 | 0.00152 | 5.64599 | 1 | 6 | 28 | endochondral ossification |
| GO:0033688 | 0.00152 | 5.64599 | 1 | 6 | 28 | regulation of osteoblast proliferation |
| GO:0036075 | 0.00152 | 5.64599 | 1 | 6 | 28 | replacement ossification |
| GO:0035556 | 0.00156 | 1.31067 | 137 | 169 | 2952 | intracellular signal transduction |
| GO:0007417 | 0.00159 | 1.51487 | 46 | 67 | 1002 | central nervous system development |
| GO:0002707 | 0.00160 | 4.67772 | 2 | 7 | 38 | negative regulation of lymphocyte mediated immunity |
| GO:0050714 | 0.00161 | 2.05388 | 12 | 24 | 268 | positive regulation of protein secretion |
| GO:0051224 | 0.00163 | 2.27568 | 9 | 19 | 193 | negative regulation of protein transport |
| GO:0032268 | 0.00164 | 1.32171 | 124 | 155 | 2679 | regulation of cellular protein metabolic process |
| GO:0048144 | 0.00167 | 3.12874 | 4 | 11 | 84 | fibroblast proliferation |
| GO:0002062 | 0.00168 | 2.67084 | 6 | 14 | 123 | chondrocyte differentiation |
| GO:0071639 | 0.00168 | 10.33508 | 1 | 4 | 12 | positive regulation of monocyte chemotactic protein-1 production |
| GO:2001198 | 0.00168 | 10.33508 | 1 | 4 | 12 | regulation of dendritic cell differentiation |
| GO:1903034 | 0.00168 | 2.32895 | 8 | 18 | 179 | regulation of response to wounding |
| GO:0007169 | 0.00169 | 1.60733 | 33 | 51 | 719 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0043491 | 0.00169 | 2.04538 | 12 | 24 | 269 | protein kinase B signaling |
| GO:0002704 | 0.00171 | 4.04451 | 2 | 8 | 49 | negative regulation of leukocyte mediated immunity |
| GO:0031644 | 0.00173 | 2.55781 | 6 | 15 | 137 | regulation of neurological system process |
| GO:0045596 | 0.00173 | 1.59021 | 35 | 53 | 755 | negative regulation of cell differentiation |
| GO:0031348 | 0.00175 | 2.11520 | 11 | 22 | 239 | negative regulation of defense response |
| GO:0006869 | 0.00178 | 1.87363 | 17 | 30 | 365 | lipid transport |
| GO:0000912 | 0.00178 | 20.65197 | 0 | 3 | 6 | assembly of actomyosin apparatus involved in cytokinesis |
| GO:0000915 | 0.00178 | 20.65197 | 0 | 3 | 6 | actomyosin contractile ring assembly |
| GO:0002924 | 0.00178 | 20.65197 | 0 | 3 | 6 | negative regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0042091 | 0.00178 | 20.65197 | 0 | 3 | 6 | interleukin-10 biosynthetic process |
| GO:0045074 | 0.00178 | 20.65197 | 0 | 3 | 6 | regulation of interleukin-10 biosynthetic process |
| GO:0070141 | 0.00178 | 20.65197 | 0 | 3 | 6 | response to UV-A |
| GO:2000503 | 0.00178 | 20.65197 | 0 | 3 | 6 | positive regulation of natural killer cell chemotaxis |
| GO:2001199 | 0.00178 | 20.65197 | 0 | 3 | 6 | negative regulation of dendritic cell differentiation |
| GO:0042535 | 0.00183 | 6.89535 | 1 | 5 | 20 | positive regulation of tumor necrosis factor biosynthetic process |
| GO:0010941 | 0.00186 | 1.38586 | 80 | 106 | 1736 | regulation of cell death |
| GO:0046631 | 0.00186 | 2.53687 | 6 | 15 | 138 | alpha-beta T cell activation |
| GO:0072676 | 0.00187 | 2.75691 | 5 | 13 | 111 | lymphocyte migration |
| GO:0032370 | 0.00188 | 3.58953 | 3 | 9 | 61 | positive regulation of lipid transport |
| GO:0070838 | 0.00196 | 1.73925 | 22 | 37 | 483 | divalent metal ion transport |
| GO:0032760 | 0.00203 | 3.04496 | 4 | 11 | 86 | positive regulation of tumor necrosis factor production |
| GO:1904950 | 0.00206 | 2.22404 | 9 | 19 | 197 | negative regulation of establishment of protein localization |
| GO:0001906 | 0.00209 | 2.34379 | 8 | 17 | 168 | cell killing |
| GO:0007156 | 0.00209 | 2.34379 | 8 | 17 | 168 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0006909 | 0.00210 | 1.85109 | 17 | 30 | 369 | phagocytosis |
| GO:0008219 | 0.00211 | 1.33640 | 105 | 133 | 2264 | cell death |
| GO:0032677 | 0.00211 | 3.24214 | 3 | 10 | 74 | regulation of interleukin-8 production |
| GO:0030098 | 0.00212 | 1.87160 | 16 | 29 | 353 | lymphocyte differentiation |
| GO:1905114 | 0.00212 | 1.63854 | 29 | 45 | 622 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0019442 | 0.00214 | Inf | 0 | 2 | 2 | tryptophan catabolic process to acetyl-CoA |
| GO:0032805 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of low-density lipoprotein particle receptor catabolic process |
| GO:0032877 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of DNA endoreduplication |
| GO:0045425 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process |
| GO:0071306 | 0.00214 | Inf | 0 | 2 | 2 | cellular response to vitamin E |
| GO:0110090 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of hippocampal neuron apoptotic process |
| GO:1901492 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of lymphangiogenesis |
| GO:1990927 | 0.00214 | Inf | 0 | 2 | 2 | calcium ion regulated lysosome exocytosis |
| GO:2000866 | 0.00214 | Inf | 0 | 2 | 2 | positive regulation of estradiol secretion |
| GO:0002823 | 0.00219 | 4.39373 | 2 | 7 | 40 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0099068 | 0.00222 | 5.17491 | 1 | 6 | 30 | postsynapse assembly |
| GO:0050728 | 0.00223 | 2.32824 | 8 | 17 | 169 | negative regulation of inflammatory response |
| GO:0010243 | 0.00224 | 1.49546 | 46 | 66 | 998 | response to organonitrogen compound |
| GO:0022600 | 0.00225 | 2.83230 | 5 | 12 | 100 | digestive system process |
| GO:0051896 | 0.00227 | 2.06697 | 11 | 22 | 244 | regulation of protein kinase B signaling |
| GO:0000278 | 0.00228 | 1.48963 | 47 | 67 | 1017 | mitotic cell cycle |
| GO:0071459 | 0.00231 | 6.46403 | 1 | 5 | 21 | protein localization to chromosome, centromeric region |
| GO:0051960 | 0.00233 | 1.51208 | 43 | 62 | 927 | regulation of nervous system development |
| GO:0002281 | 0.00234 | 9.18622 | 1 | 4 | 13 | macrophage activation involved in immune response |
| GO:0035641 | 0.00234 | 9.18622 | 1 | 4 | 13 | locomotory exploration behavior |
| GO:0071772 | 0.00237 | 2.31289 | 8 | 17 | 170 | response to BMP |
| GO:0071773 | 0.00237 | 2.31289 | 8 | 17 | 170 | cellular response to BMP stimulus |
| GO:0002688 | 0.00238 | 2.67457 | 5 | 13 | 114 | regulation of leukocyte chemotaxis |
| GO:0072511 | 0.00242 | 1.71557 | 23 | 37 | 489 | divalent inorganic cation transport |
| GO:1904018 | 0.00243 | 2.09481 | 11 | 21 | 230 | positive regulation of vasculature development |
| GO:0045787 | 0.00243 | 1.81148 | 18 | 31 | 389 | positive regulation of cell cycle |
| GO:0002495 | 0.00244 | 2.80032 | 5 | 12 | 101 | antigen processing and presentation of peptide antigen via MHC class II |
| GO:0002576 | 0.00245 | 2.55297 | 6 | 14 | 128 | platelet degranulation |
| GO:0002687 | 0.00245 | 2.55297 | 6 | 14 | 128 | positive regulation of leukocyte migration |
| GO:0051291 | 0.00245 | 2.55297 | 6 | 14 | 128 | protein heterooligomerization |
| GO:0048659 | 0.00252 | 2.29774 | 8 | 17 | 171 | smooth muscle cell proliferation |
| GO:0048878 | 0.00253 | 1.44738 | 55 | 76 | 1187 | chemical homeostasis |
| GO:0009719 | 0.00256 | 1.37956 | 77 | 101 | 1658 | response to endogenous stimulus |
| GO:0032612 | 0.00257 | 2.64820 | 5 | 13 | 115 | interleukin-1 production |
| GO:0002703 | 0.00259 | 2.17466 | 9 | 19 | 201 | regulation of leukocyte mediated immunity |
| GO:0009617 | 0.00262 | 1.58483 | 32 | 49 | 699 | response to bacterium |
| GO:0048519 | 0.00262 | 1.23046 | 272 | 310 | 5869 | negative regulation of biological process |
| GO:0045670 | 0.00263 | 3.39316 | 3 | 9 | 64 | regulation of osteoclast differentiation |
| GO:0033687 | 0.00265 | 4.96764 | 1 | 6 | 31 | osteoblast proliferation |
| GO:0040020 | 0.00265 | 4.96764 | 1 | 6 | 31 | regulation of meiotic nuclear division |
| GO:0002504 | 0.00266 | 2.76905 | 5 | 12 | 102 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0015837 | 0.00266 | 2.76905 | 5 | 12 | 102 | amine transport |
| GO:0098869 | 0.00266 | 2.76905 | 5 | 12 | 102 | cellular oxidant detoxification |
| GO:0006874 | 0.00266 | 1.73280 | 21 | 35 | 458 | cellular calcium ion homeostasis |
| GO:0019725 | 0.00274 | 1.49032 | 45 | 64 | 970 | cellular homeostasis |
| GO:0072503 | 0.00277 | 1.70013 | 23 | 37 | 493 | cellular divalent inorganic cation homeostasis |
| GO:0019220 | 0.00279 | 1.35970 | 84 | 109 | 1816 | regulation of phosphate metabolic process |
| GO:1902107 | 0.00282 | 2.41806 | 7 | 15 | 144 | positive regulation of leukocyte differentiation |
| GO:0010469 | 0.00285 | 2.26803 | 8 | 17 | 173 | regulation of signaling receptor activity |
| GO:0030195 | 0.00286 | 3.68417 | 2 | 8 | 53 | negative regulation of blood coagulation |
| GO:1902099 | 0.00286 | 3.68417 | 2 | 8 | 53 | regulation of metaphase/anaphase transition of cell cycle |
| GO:1903307 | 0.00286 | 3.68417 | 2 | 8 | 53 | positive regulation of regulated secretory pathway |
| GO:0006814 | 0.00287 | 2.10472 | 10 | 20 | 218 | sodium ion transport |
| GO:1902533 | 0.00288 | 1.46110 | 50 | 70 | 1082 | positive regulation of intracellular signal transduction |
| GO:0031342 | 0.00288 | 6.08345 | 1 | 5 | 22 | negative regulation of cell killing |
| GO:0032928 | 0.00288 | 6.08345 | 1 | 5 | 22 | regulation of superoxide anion generation |
| GO:0051174 | 0.00289 | 1.35794 | 84 | 109 | 1818 | regulation of phosphorus metabolic process |
| GO:0045778 | 0.00292 | 2.89014 | 4 | 11 | 90 | positive regulation of ossification |
| GO:0002548 | 0.00294 | 3.33238 | 3 | 9 | 65 | monocyte chemotaxis |
| GO:0010817 | 0.00295 | 1.66844 | 25 | 39 | 529 | regulation of hormone levels |
| GO:0015672 | 0.00295 | 1.66844 | 25 | 39 | 529 | monovalent inorganic cation transport |
| GO:0042592 | 0.00297 | 1.34807 | 89 | 114 | 1916 | homeostatic process |
| GO:0007196 | 0.00301 | 15.48811 | 0 | 3 | 7 | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway |
| GO:0031622 | 0.00301 | 15.48811 | 0 | 3 | 7 | positive regulation of fever generation |
| GO:0032466 | 0.00301 | 15.48811 | 0 | 3 | 7 | negative regulation of cytokinesis |
| GO:0044837 | 0.00301 | 15.48811 | 0 | 3 | 7 | actomyosin contractile ring organization |
| GO:0046643 | 0.00301 | 15.48811 | 0 | 3 | 7 | regulation of gamma-delta T cell activation |
| GO:0051256 | 0.00301 | 15.48811 | 0 | 3 | 7 | mitotic spindle midzone assembly |
| GO:0060012 | 0.00301 | 15.48811 | 0 | 3 | 7 | synaptic transmission, glycinergic |
| GO:0060710 | 0.00301 | 15.48811 | 0 | 3 | 7 | chorio-allantoic fusion |
| GO:0060717 | 0.00301 | 15.48811 | 0 | 3 | 7 | chorion development |
| GO:2000542 | 0.00301 | 15.48811 | 0 | 3 | 7 | negative regulation of gastrulation |
| GO:0050801 | 0.00301 | 1.53128 | 38 | 55 | 811 | ion homeostasis |
| GO:0030003 | 0.00309 | 1.59406 | 30 | 46 | 652 | cellular cation homeostasis |
| GO:0046883 | 0.00311 | 1.97416 | 12 | 23 | 266 | regulation of hormone secretion |
| GO:0019233 | 0.00312 | 2.70855 | 5 | 12 | 104 | sensory perception of pain |
| GO:0030593 | 0.00312 | 2.70855 | 5 | 12 | 104 | neutrophil chemotaxis |
| GO:0042744 | 0.00313 | 4.77631 | 1 | 6 | 32 | hydrogen peroxide catabolic process |
| GO:0001910 | 0.00314 | 3.05074 | 4 | 10 | 78 | regulation of leukocyte mediated cytotoxicity |
| GO:1903305 | 0.00314 | 2.31135 | 7 | 16 | 160 | regulation of regulated secretory pathway |
| GO:0018108 | 0.00318 | 1.81453 | 17 | 29 | 363 | peptidyl-tyrosine phosphorylation |
| GO:0014909 | 0.00318 | 2.85385 | 4 | 11 | 91 | smooth muscle cell migration |
| GO:0051707 | 0.00319 | 1.47046 | 47 | 66 | 1013 | response to other organism |
| GO:1900047 | 0.00323 | 3.60388 | 3 | 8 | 54 | negative regulation of hemostasis |
| GO:0042325 | 0.00326 | 1.37286 | 75 | 98 | 1614 | regulation of phosphorylation |
| GO:0071900 | 0.00327 | 1.66920 | 24 | 38 | 515 | regulation of protein serine/threonine kinase activity |
| GO:0031401 | 0.00331 | 1.42346 | 57 | 78 | 1237 | positive regulation of protein modification process |
| GO:0043207 | 0.00334 | 1.46719 | 47 | 66 | 1015 | response to external biotic stimulus |
| GO:0050850 | 0.00335 | 4.02690 | 2 | 7 | 43 | positive regulation of calcium-mediated signaling |
| GO:0034765 | 0.00351 | 1.68632 | 22 | 36 | 483 | regulation of ion transmembrane transport |
| GO:0032703 | 0.00354 | 5.74516 | 1 | 5 | 23 | negative regulation of interleukin-2 production |
| GO:0032959 | 0.00354 | 5.74516 | 1 | 5 | 23 | inositol trisphosphate biosynthetic process |
| GO:0072215 | 0.00354 | 5.74516 | 1 | 5 | 23 | regulation of metanephros development |
| GO:0018212 | 0.00357 | 1.79806 | 17 | 29 | 366 | peptidyl-tyrosine modification |
| GO:0002886 | 0.00362 | 3.52700 | 3 | 8 | 55 | regulation of myeloid leukocyte mediated immunity |
| GO:0046456 | 0.00362 | 3.52700 | 3 | 8 | 55 | icosanoid biosynthetic process |
| GO:2000242 | 0.00362 | 3.52700 | 3 | 8 | 55 | negative regulation of reproductive process |
| GO:0007052 | 0.00366 | 2.65062 | 5 | 12 | 106 | mitotic spindle organization |
| GO:1903047 | 0.00367 | 1.49827 | 40 | 58 | 873 | mitotic cell cycle process |
| GO:0002920 | 0.00373 | 2.42450 | 6 | 14 | 134 | regulation of humoral immune response |
| GO:0046683 | 0.00373 | 2.42450 | 6 | 14 | 134 | response to organophosphorus |
| GO:0042391 | 0.00374 | 1.72145 | 20 | 33 | 434 | regulation of membrane potential |
| GO:0010942 | 0.00377 | 1.54502 | 34 | 50 | 730 | positive regulation of cell death |
| GO:0099173 | 0.00377 | 2.26379 | 8 | 16 | 163 | postsynapse organization |
| GO:0003073 | 0.00377 | 2.78393 | 4 | 11 | 93 | regulation of systemic arterial blood pressure |
| GO:1901654 | 0.00382 | 2.14093 | 9 | 18 | 193 | response to ketone |
| GO:0051222 | 0.00386 | 1.73357 | 19 | 32 | 418 | positive regulation of protein transport |
| GO:0014074 | 0.00390 | 2.32717 | 7 | 15 | 149 | response to purine-containing compound |
| GO:0044784 | 0.00406 | 3.45333 | 3 | 8 | 56 | metaphase/anaphase transition of cell cycle |
| GO:0007216 | 0.00415 | 7.51515 | 1 | 4 | 15 | G protein-coupled glutamate receptor signaling pathway |
| GO:0015671 | 0.00415 | 7.51515 | 1 | 4 | 15 | oxygen transport |
| GO:0030852 | 0.00415 | 7.51515 | 1 | 4 | 15 | regulation of granulocyte differentiation |
| GO:0045410 | 0.00415 | 7.51515 | 1 | 4 | 15 | positive regulation of interleukin-6 biosynthetic process |
| GO:0090197 | 0.00415 | 7.51515 | 1 | 4 | 15 | positive regulation of chemokine secretion |
| GO:0090494 | 0.00415 | 7.51515 | 1 | 4 | 15 | dopamine uptake |
| GO:0050777 | 0.00416 | 2.30980 | 7 | 15 | 150 | negative regulation of immune response |
| GO:0022603 | 0.00419 | 1.42457 | 54 | 73 | 1155 | regulation of anatomical structure morphogenesis |
| GO:0007093 | 0.00425 | 2.23315 | 8 | 16 | 165 | mitotic cell cycle checkpoint |
| GO:0007094 | 0.00430 | 4.43464 | 2 | 6 | 34 | mitotic spindle assembly checkpoint |
| GO:0031577 | 0.00430 | 4.43464 | 2 | 6 | 34 | spindle checkpoint |
| GO:0042533 | 0.00430 | 4.43464 | 2 | 6 | 34 | tumor necrosis factor biosynthetic process |
| GO:0042534 | 0.00430 | 4.43464 | 2 | 6 | 34 | regulation of tumor necrosis factor biosynthetic process |
| GO:0048048 | 0.00430 | 4.43464 | 2 | 6 | 34 | embryonic eye morphogenesis |
| GO:0071173 | 0.00430 | 4.43464 | 2 | 6 | 34 | spindle assembly checkpoint |
| GO:0071174 | 0.00430 | 4.43464 | 2 | 6 | 34 | mitotic spindle checkpoint |
| GO:0034505 | 0.00430 | 5.44247 | 1 | 5 | 24 | tooth mineralization |
| GO:0051446 | 0.00430 | 5.44247 | 1 | 5 | 24 | positive regulation of meiotic cell cycle |
| GO:0060284 | 0.00433 | 1.46570 | 44 | 62 | 953 | regulation of cell development |
| GO:0009914 | 0.00439 | 1.83308 | 15 | 26 | 322 | hormone transport |
| GO:2000243 | 0.00442 | 3.10952 | 3 | 9 | 69 | positive regulation of reproductive process |
| GO:1901342 | 0.00444 | 1.71539 | 20 | 32 | 422 | regulation of vasculature development |
| GO:0042100 | 0.00445 | 2.71734 | 4 | 11 | 95 | B cell proliferation |
| GO:0019932 | 0.00445 | 1.69976 | 20 | 33 | 439 | second-messenger-mediated signaling |
| GO:0006873 | 0.00445 | 1.55940 | 31 | 46 | 665 | cellular ion homeostasis |
| GO:0032637 | 0.00452 | 2.88060 | 4 | 10 | 82 | interleukin-8 production |
| GO:1905954 | 0.00452 | 2.88060 | 4 | 10 | 82 | positive regulation of lipid localization |
| GO:0048015 | 0.00452 | 2.15642 | 8 | 17 | 181 | phosphatidylinositol-mediated signaling |
| GO:0042743 | 0.00454 | 3.38266 | 3 | 8 | 57 | hydrogen peroxide metabolic process |
| GO:0050819 | 0.00454 | 3.38266 | 3 | 8 | 57 | negative regulation of coagulation |
| GO:0044057 | 0.00459 | 1.58173 | 28 | 43 | 613 | regulation of system process |
| GO:0071621 | 0.00462 | 2.45449 | 6 | 13 | 123 | granulocyte chemotaxis |
| GO:0002765 | 0.00466 | 12.38979 | 0 | 3 | 8 | immune response-inhibiting signal transduction |
| GO:0031620 | 0.00466 | 12.38979 | 0 | 3 | 8 | regulation of fever generation |
| GO:0060075 | 0.00466 | 12.38979 | 0 | 3 | 8 | regulation of resting membrane potential |
| GO:1903012 | 0.00466 | 12.38979 | 0 | 3 | 8 | positive regulation of bone development |
| GO:0043270 | 0.00468 | 1.90268 | 13 | 23 | 275 | positive regulation of ion transport |
| GO:0006875 | 0.00474 | 1.59695 | 27 | 41 | 579 | cellular metal ion homeostasis |
| GO:0032720 | 0.00487 | 3.05837 | 3 | 9 | 70 | negative regulation of tumor necrosis factor production |
| GO:0050766 | 0.00487 | 3.05837 | 3 | 9 | 70 | positive regulation of phagocytosis |
| GO:0072091 | 0.00487 | 3.05837 | 3 | 9 | 70 | regulation of stem cell proliferation |
| GO:0007411 | 0.00489 | 1.89506 | 13 | 23 | 276 | axon guidance |
| GO:0048145 | 0.00493 | 2.84098 | 4 | 10 | 83 | regulation of fibroblast proliferation |
| GO:0098659 | 0.00493 | 2.84098 | 4 | 10 | 83 | inorganic cation import across plasma membrane |
| GO:0099587 | 0.00493 | 2.84098 | 4 | 10 | 83 | inorganic ion import across plasma membrane |
| GO:0043300 | 0.00494 | 3.71651 | 2 | 7 | 46 | regulation of leukocyte degranulation |
| GO:0045776 | 0.00494 | 3.71651 | 2 | 7 | 46 | negative regulation of blood pressure |
| GO:0098739 | 0.00495 | 2.54186 | 5 | 12 | 110 | import across plasma membrane |
| GO:0007626 | 0.00499 | 2.08087 | 9 | 18 | 198 | locomotory behavior |
| GO:0045807 | 0.00500 | 2.25921 | 7 | 15 | 153 | positive regulation of endocytosis |
| GO:0097485 | 0.00510 | 1.88749 | 13 | 23 | 277 | neuron projection guidance |
| GO:0002253 | 0.00515 | 1.52391 | 34 | 49 | 724 | activation of immune response |
| GO:0003071 | 0.00517 | 5.17006 | 1 | 5 | 25 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0035235 | 0.00517 | 5.17006 | 1 | 5 | 25 | ionotropic glutamate receptor signaling pathway |
| GO:1905809 | 0.00517 | 5.17006 | 1 | 5 | 25 | negative regulation of synapse organization |
| GO:0030316 | 0.00521 | 2.65385 | 4 | 11 | 97 | osteoclast differentiation |
| GO:0051591 | 0.00521 | 2.65385 | 4 | 11 | 97 | response to cAMP |
| GO:0002237 | 0.00526 | 1.78319 | 16 | 27 | 343 | response to molecule of bacterial origin |
| GO:0010875 | 0.00533 | 6.88850 | 1 | 4 | 16 | positive regulation of cholesterol efflux |
| GO:0030889 | 0.00533 | 6.88850 | 1 | 4 | 16 | negative regulation of B cell proliferation |
| GO:0043031 | 0.00533 | 6.88850 | 1 | 4 | 16 | negative regulation of macrophage activation |
| GO:0048791 | 0.00533 | 6.88850 | 1 | 4 | 16 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0090493 | 0.00533 | 6.88850 | 1 | 4 | 16 | catecholamine uptake |
| GO:1905153 | 0.00533 | 6.88850 | 1 | 4 | 16 | regulation of membrane invagination |
| GO:0048017 | 0.00533 | 2.11732 | 9 | 17 | 184 | inositol lipid-mediated signaling |
| GO:0048660 | 0.00535 | 2.17428 | 8 | 16 | 169 | regulation of smooth muscle cell proliferation |
| GO:0014910 | 0.00537 | 2.80243 | 4 | 10 | 84 | regulation of smooth muscle cell migration |
| GO:0010959 | 0.00543 | 1.72149 | 18 | 30 | 394 | regulation of metal ion transport |
| GO:0097237 | 0.00556 | 1.93536 | 11 | 21 | 247 | cellular response to toxic substance |
| GO:0031952 | 0.00557 | 3.62340 | 2 | 7 | 47 | regulation of protein autophosphorylation |
| GO:0019886 | 0.00563 | 2.62319 | 5 | 11 | 98 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
| GO:0046879 | 0.00567 | 1.81662 | 14 | 25 | 312 | hormone secretion |
| GO:1990748 | 0.00571 | 2.49074 | 5 | 12 | 112 | cellular detoxification |
| GO:0034762 | 0.00573 | 1.58650 | 26 | 40 | 568 | regulation of transmembrane transport |
| GO:0050890 | 0.00575 | 1.83951 | 14 | 24 | 296 | cognition |
| GO:0045841 | 0.00575 | 4.13853 | 2 | 6 | 36 | negative regulation of mitotic metaphase/anaphase transition |
| GO:0090322 | 0.00575 | 4.13853 | 2 | 6 | 36 | regulation of superoxide metabolic process |
| GO:1903556 | 0.00587 | 2.96095 | 3 | 9 | 72 | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0097530 | 0.00587 | 2.28996 | 7 | 14 | 141 | granulocyte migration |
| GO:0015711 | 0.00594 | 1.63750 | 22 | 35 | 482 | organic anion transport |
| GO:0017157 | 0.00597 | 1.99712 | 10 | 19 | 217 | regulation of exocytosis |
| GO:0003006 | 0.00599 | 1.53119 | 31 | 46 | 676 | developmental process involved in reproduction |
| GO:0051604 | 0.00604 | 1.70713 | 18 | 30 | 397 | protein maturation |
| GO:0048608 | 0.00604 | 1.67583 | 20 | 32 | 431 | reproductive structure development |
| GO:0032368 | 0.00605 | 2.36783 | 6 | 13 | 127 | regulation of lipid transport |
| GO:0032270 | 0.00606 | 1.34231 | 75 | 96 | 1611 | positive regulation of cellular protein metabolic process |
| GO:0003081 | 0.00616 | 4.92359 | 1 | 5 | 26 | regulation of systemic arterial blood pressure by renin-angiotensin |
| GO:0032957 | 0.00616 | 4.92359 | 1 | 5 | 26 | inositol trisphosphate metabolic process |
| GO:0035640 | 0.00616 | 4.92359 | 1 | 5 | 26 | exploration behavior |
| GO:0045992 | 0.00616 | 4.92359 | 1 | 5 | 26 | negative regulation of embryonic development |
| GO:0060669 | 0.00616 | 4.92359 | 1 | 5 | 26 | embryonic placenta morphogenesis |
| GO:0001810 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of type I hypersensitivity |
| GO:0002399 | 0.00623 | 41.26072 | 0 | 2 | 3 | MHC class II protein complex assembly |
| GO:0002503 | 0.00623 | 41.26072 | 0 | 2 | 3 | peptide antigen assembly with MHC class II protein complex |
| GO:0002541 | 0.00623 | 41.26072 | 0 | 2 | 3 | activation of plasma proteins involved in acute inflammatory response |
| GO:0002774 | 0.00623 | 41.26072 | 0 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
| GO:0008315 | 0.00623 | 41.26072 | 0 | 2 | 3 | G2/MI transition of meiotic cell cycle |
| GO:0016068 | 0.00623 | 41.26072 | 0 | 2 | 3 | type I hypersensitivity |
| GO:0030185 | 0.00623 | 41.26072 | 0 | 2 | 3 | nitric oxide transport |
| GO:0030450 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of complement activation, classical pathway |
| GO:0035938 | 0.00623 | 41.26072 | 0 | 2 | 3 | estradiol secretion |
| GO:0043420 | 0.00623 | 41.26072 | 0 | 2 | 3 | anthranilate metabolic process |
| GO:0044785 | 0.00623 | 41.26072 | 0 | 2 | 3 | metaphase/anaphase transition of meiotic cell cycle |
| GO:0045423 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process |
| GO:0045588 | 0.00623 | 41.26072 | 0 | 2 | 3 | positive regulation of gamma-delta T cell differentiation |
| GO:0045959 | 0.00623 | 41.26072 | 0 | 2 | 3 | negative regulation of complement activation, classical pathway |
| GO:0050955 | 0.00623 | 41.26072 | 0 | 2 | 3 | thermoception |
| GO:0071492 | 0.00623 | 41.26072 | 0 | 2 | 3 | cellular response to UV-A |
| GO:0090634 | 0.00623 | 41.26072 | 0 | 2 | 3 | microglial cell mediated cytotoxicity |
| GO:0097325 | 0.00623 | 41.26072 | 0 | 2 | 3 | melanocyte proliferation |
| GO:0098971 | 0.00623 | 41.26072 | 0 | 2 | 3 | anterograde dendritic transport of neurotransmitter receptor complex |
| GO:0099538 | 0.00623 | 41.26072 | 0 | 2 | 3 | synaptic signaling via neuropeptide |
| GO:0110030 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of G2/MI transition of meiotic cell cycle |
| GO:0110032 | 0.00623 | 41.26072 | 0 | 2 | 3 | positive regulation of G2/MI transition of meiotic cell cycle |
| GO:0150064 | 0.00623 | 41.26072 | 0 | 2 | 3 | vertebrate eye-specific patterning |
| GO:1902102 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of metaphase/anaphase transition of meiotic cell cycle |
| GO:1903027 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of opsonization |
| GO:1903225 | 0.00623 | 41.26072 | 0 | 2 | 3 | negative regulation of endodermal cell differentiation |
| GO:1903615 | 0.00623 | 41.26072 | 0 | 2 | 3 | positive regulation of protein tyrosine phosphatase activity |
| GO:1903804 | 0.00623 | 41.26072 | 0 | 2 | 3 | glycine import across plasma membrane |
| GO:1904149 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of microglial cell mediated cytotoxicity |
| GO:1904151 | 0.00623 | 41.26072 | 0 | 2 | 3 | positive regulation of microglial cell mediated cytotoxicity |
| GO:1905132 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of meiotic chromosome separation |
| GO:2000361 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of prostaglandin-E synthase activity |
| GO:2000363 | 0.00623 | 41.26072 | 0 | 2 | 3 | positive regulation of prostaglandin-E synthase activity |
| GO:2000864 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of estradiol secretion |
| GO:2001183 | 0.00623 | 41.26072 | 0 | 2 | 3 | negative regulation of interleukin-12 secretion |
| GO:2001260 | 0.00623 | 41.26072 | 0 | 2 | 3 | regulation of semaphorin-plexin signaling pathway |
| GO:0019722 | 0.00626 | 1.98697 | 10 | 19 | 218 | calcium-mediated signaling |
| GO:0050807 | 0.00626 | 1.98697 | 10 | 19 | 218 | regulation of synapse organization |
| GO:0002762 | 0.00627 | 3.53482 | 2 | 7 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:0016339 | 0.00627 | 3.53482 | 2 | 7 | 48 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0030850 | 0.00627 | 3.53482 | 2 | 7 | 48 | prostate gland development |
| GO:0006801 | 0.00643 | 2.91452 | 3 | 9 | 73 | superoxide metabolic process |
| GO:0060350 | 0.00643 | 2.91452 | 3 | 9 | 73 | endochondral bone morphogenesis |
| GO:0007215 | 0.00655 | 2.56396 | 5 | 11 | 100 | glutamate receptor signaling pathway |
| GO:2001023 | 0.00655 | 2.56396 | 5 | 11 | 100 | regulation of response to drug |
| GO:0006690 | 0.00657 | 2.44162 | 5 | 12 | 114 | icosanoid metabolic process |
| GO:0060349 | 0.00657 | 2.44162 | 5 | 12 | 114 | bone morphogenesis |
| GO:0032941 | 0.00660 | 4.00481 | 2 | 6 | 37 | secretion by tissue |
| GO:1902100 | 0.00660 | 4.00481 | 2 | 6 | 37 | negative regulation of metaphase/anaphase transition of cell cycle |
| GO:2000403 | 0.00660 | 4.00481 | 2 | 6 | 37 | positive regulation of lymphocyte migration |
| GO:0150063 | 0.00665 | 1.72876 | 17 | 28 | 366 | visual system development |
| GO:0061458 | 0.00667 | 1.66304 | 20 | 32 | 434 | reproductive system development |
| GO:0045765 | 0.00668 | 1.71005 | 18 | 29 | 383 | regulation of angiogenesis |
| GO:0010876 | 0.00670 | 1.69299 | 19 | 30 | 400 | lipid localization |
| GO:0009607 | 0.00670 | 1.41663 | 49 | 66 | 1047 | response to biotic stimulus |
| GO:0031649 | 0.00671 | 6.35826 | 1 | 4 | 17 | heat generation |
| GO:0045072 | 0.00671 | 6.35826 | 1 | 4 | 17 | regulation of interferon-gamma biosynthetic process |
| GO:0010564 | 0.00673 | 1.48125 | 37 | 52 | 789 | regulation of cell cycle process |
| GO:0000022 | 0.00675 | 10.32425 | 0 | 3 | 9 | mitotic spindle elongation |
| GO:0060242 | 0.00675 | 10.32425 | 0 | 3 | 9 | contact inhibition |
| GO:0099641 | 0.00675 | 10.32425 | 0 | 3 | 9 | anterograde axonal protein transport |
| GO:1903867 | 0.00675 | 10.32425 | 0 | 3 | 9 | extraembryonic membrane development |
| GO:2000501 | 0.00675 | 10.32425 | 0 | 3 | 9 | regulation of natural killer cell chemotaxis |
| GO:0071840 | 0.00676 | 1.19626 | 310 | 345 | 6697 | cellular component organization or biogenesis |
| GO:0001892 | 0.00688 | 2.69279 | 4 | 10 | 87 | embryonic placenta development |
| GO:0002690 | 0.00688 | 2.69279 | 4 | 10 | 87 | positive regulation of leukocyte chemotaxis |
| GO:0071216 | 0.00695 | 1.92735 | 11 | 20 | 236 | cellular response to biotic stimulus |
| GO:0050710 | 0.00702 | 2.86952 | 3 | 9 | 74 | negative regulation of cytokine secretion |
| GO:0001913 | 0.00703 | 3.45047 | 2 | 7 | 49 | T cell mediated cytotoxicity |
| GO:0030449 | 0.00704 | 2.41778 | 5 | 12 | 115 | regulation of complement activation |
| GO:0032611 | 0.00705 | 2.53532 | 5 | 11 | 101 | interleukin-1 beta production |
| GO:0045859 | 0.00723 | 1.47498 | 37 | 52 | 792 | regulation of protein kinase activity |
| GO:0015721 | 0.00728 | 4.69952 | 1 | 5 | 27 | bile acid and bile salt transport |
| GO:0032673 | 0.00728 | 4.69952 | 1 | 5 | 27 | regulation of interleukin-4 production |
| GO:0007600 | 0.00736 | 1.42523 | 45 | 62 | 977 | sensory perception |
| GO:0045921 | 0.00744 | 2.65812 | 4 | 10 | 88 | positive regulation of exocytosis |
| GO:0002819 | 0.00750 | 2.14929 | 7 | 15 | 160 | regulation of adaptive immune response |
| GO:0055082 | 0.00753 | 1.46589 | 38 | 53 | 812 | cellular chemical homeostasis |
| GO:2000257 | 0.00753 | 2.39440 | 5 | 12 | 116 | regulation of protein activation cascade |
| GO:0015804 | 0.00754 | 3.87944 | 2 | 6 | 38 | neutral amino acid transport |
| GO:0016572 | 0.00754 | 3.87944 | 2 | 6 | 38 | histone phosphorylation |
| GO:1905818 | 0.00758 | 3.06859 | 3 | 8 | 62 | regulation of chromosome separation |
| GO:0033993 | 0.00762 | 1.43530 | 43 | 59 | 923 | response to lipid |
| GO:0009790 | 0.00780 | 1.41288 | 47 | 64 | 1017 | embryo development |
| GO:0098754 | 0.00781 | 2.28705 | 6 | 13 | 131 | detoxification |
| GO:1902850 | 0.00781 | 2.28705 | 6 | 13 | 131 | microtubule cytoskeleton organization involved in mitosis |
| GO:0001505 | 0.00790 | 1.72212 | 16 | 27 | 354 | regulation of neurotransmitter levels |
| GO:0051250 | 0.00793 | 2.20260 | 7 | 14 | 146 | negative regulation of lymphocyte activation |
| GO:0051384 | 0.00793 | 2.20260 | 7 | 14 | 146 | response to glucocorticoid |
| GO:0048880 | 0.00793 | 1.70307 | 17 | 28 | 371 | sensory system development |
| GO:0032465 | 0.00805 | 2.62432 | 4 | 10 | 89 | regulation of cytokinesis |
| GO:0018958 | 0.00815 | 2.47993 | 5 | 11 | 103 | phenol-containing compound metabolic process |
| GO:0032652 | 0.00815 | 2.47993 | 5 | 11 | 103 | regulation of interleukin-1 production |
| GO:0051983 | 0.00815 | 2.47993 | 5 | 11 | 103 | regulation of chromosome segregation |
| GO:0007611 | 0.00826 | 1.86029 | 12 | 21 | 256 | learning or memory |
| GO:0032693 | 0.00832 | 5.90377 | 1 | 4 | 18 | negative regulation of interleukin-10 production |
| GO:0042095 | 0.00832 | 5.90377 | 1 | 4 | 18 | interferon-gamma biosynthetic process |
| GO:0051782 | 0.00832 | 5.90377 | 1 | 4 | 18 | negative regulation of cell division |
| GO:0090196 | 0.00832 | 5.90377 | 1 | 4 | 18 | regulation of chemokine secretion |
| GO:0007492 | 0.00834 | 2.78355 | 4 | 9 | 76 | endoderm development |
| GO:0030500 | 0.00834 | 2.78355 | 4 | 9 | 76 | regulation of bone mineralization |
| GO:0016310 | 0.00850 | 1.26967 | 112 | 136 | 2417 | phosphorylation |
| GO:0007257 | 0.00857 | 3.76167 | 2 | 6 | 39 | activation of JUN kinase activity |
| GO:0032506 | 0.00857 | 3.76167 | 2 | 6 | 39 | cytokinetic process |
| GO:2000816 | 0.00857 | 3.76167 | 2 | 6 | 39 | negative regulation of mitotic sister chromatid separation |
| GO:1990266 | 0.00859 | 2.34896 | 5 | 12 | 118 | neutrophil migration |
| GO:0120036 | 0.00862 | 1.33564 | 69 | 89 | 1497 | plasma membrane bounded cell projection organization |
| GO:0045132 | 0.00869 | 2.59137 | 4 | 10 | 90 | meiotic chromosome segregation |
| GO:0046849 | 0.00869 | 2.59137 | 4 | 10 | 90 | bone remodeling |
| GO:0051304 | 0.00869 | 2.59137 | 4 | 10 | 90 | chromosome separation |
| GO:0071674 | 0.00869 | 2.59137 | 4 | 10 | 90 | mononuclear cell migration |
| GO:1903035 | 0.00869 | 2.59137 | 4 | 10 | 90 | negative regulation of response to wounding |
| GO:0042063 | 0.00872 | 1.79426 | 13 | 23 | 290 | gliogenesis |
| GO:0014812 | 0.00874 | 2.45312 | 5 | 11 | 104 | muscle cell migration |
| GO:0002712 | 0.00875 | 3.29326 | 2 | 7 | 51 | regulation of B cell mediated immunity |
| GO:0002889 | 0.00875 | 3.29326 | 2 | 7 | 51 | regulation of immunoglobulin mediated immune response |
| GO:0030071 | 0.00875 | 3.29326 | 2 | 7 | 51 | regulation of mitotic metaphase/anaphase transition |
| GO:0048146 | 0.00875 | 3.29326 | 2 | 7 | 51 | positive regulation of fibroblast proliferation |
| GO:0051668 | 0.00890 | 2.16948 | 7 | 14 | 148 | localization within membrane |
| GO:0048678 | 0.00907 | 2.74246 | 4 | 9 | 77 | response to axon injury |
| GO:0048771 | 0.00916 | 2.03973 | 8 | 16 | 179 | tissue remodeling |
| GO:0071417 | 0.00921 | 1.53550 | 27 | 40 | 585 | cellular response to organonitrogen compound |
| GO:0002713 | 0.00931 | 8.84886 | 0 | 3 | 10 | negative regulation of B cell mediated immunity |
| GO:0002890 | 0.00931 | 8.84886 | 0 | 3 | 10 | negative regulation of immunoglobulin mediated immune response |
| GO:0006569 | 0.00931 | 8.84886 | 0 | 3 | 10 | tryptophan catabolic process |
| GO:0007135 | 0.00931 | 8.84886 | 0 | 3 | 10 | meiosis II |
| GO:0016102 | 0.00931 | 8.84886 | 0 | 3 | 10 | diterpenoid biosynthetic process |
| GO:0033690 | 0.00931 | 8.84886 | 0 | 3 | 10 | positive regulation of osteoblast proliferation |
| GO:0042436 | 0.00931 | 8.84886 | 0 | 3 | 10 | indole-containing compound catabolic process |
| GO:0046218 | 0.00931 | 8.84886 | 0 | 3 | 10 | indolalkylamine catabolic process |
| GO:0051231 | 0.00931 | 8.84886 | 0 | 3 | 10 | spindle elongation |
| GO:0051255 | 0.00931 | 8.84886 | 0 | 3 | 10 | spindle midzone assembly |
| GO:0060281 | 0.00931 | 8.84886 | 0 | 3 | 10 | regulation of oocyte development |
| GO:0060346 | 0.00931 | 8.84886 | 0 | 3 | 10 | bone trabecula formation |
| GO:0061983 | 0.00931 | 8.84886 | 0 | 3 | 10 | meiosis II cell cycle process |
| GO:0070170 | 0.00931 | 8.84886 | 0 | 3 | 10 | regulation of tooth mineralization |
| GO:1905879 | 0.00931 | 8.84886 | 0 | 3 | 10 | regulation of oogenesis |
| GO:0007009 | 0.00937 | 2.42689 | 5 | 11 | 105 | plasma membrane organization |
| GO:0048592 | 0.00942 | 2.15328 | 7 | 14 | 149 | eye morphogenesis |
| GO:0050803 | 0.00950 | 1.90002 | 11 | 19 | 227 | regulation of synapse structure or activity |
| GO:0070613 | 0.00964 | 2.02718 | 8 | 16 | 180 | regulation of protein processing |
| GO:0071466 | 0.00964 | 2.02718 | 8 | 16 | 180 | cellular response to xenobiotic stimulus |
| GO:0001941 | 0.00970 | 3.65083 | 2 | 6 | 40 | postsynaptic membrane organization |
| GO:0001990 | 0.00970 | 3.65083 | 2 | 6 | 40 | regulation of systemic arterial blood pressure by hormone |
| GO:0032467 | 0.00970 | 3.65083 | 2 | 6 | 40 | positive regulation of cytokinesis |
| GO:0071548 | 0.00970 | 3.65083 | 2 | 6 | 40 | response to dexamethasone |
| GO:1905819 | 0.00970 | 3.65083 | 2 | 6 | 40 | negative regulation of chromosome separation |
| GO:0072089 | 0.00977 | 2.30520 | 6 | 12 | 120 | stem cell proliferation |
| GO:0072347 | 0.00985 | 2.70256 | 4 | 9 | 78 | response to anesthetic |
| GO:0010575 | 0.00992 | 4.30741 | 1 | 5 | 29 | positive regulation of vascular endothelial growth factor production |
| GO:0060359 | 0.00995 | 2.21157 | 6 | 13 | 135 | response to ammonium ion |
| GO:0007186 | 0.00997 | 1.34185 | 64 | 82 | 1371 | G protein-coupled receptor signaling pathway |
| GO:0051963 | 0.01003 | 2.40121 | 5 | 11 | 106 | regulation of synapse assembly |
| GO:0072678 | 0.01003 | 2.90659 | 3 | 8 | 65 | T cell migration |
| GO:0010721 | 0.01008 | 1.70412 | 16 | 26 | 344 | negative regulation of cell development |
| GO:0022408 | 0.01013 | 2.01478 | 8 | 16 | 181 | negative regulation of cell-cell adhesion |
| GO:0001991 | 0.01016 | 5.50987 | 1 | 4 | 19 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
| GO:0002710 | 0.01016 | 5.50987 | 1 | 4 | 19 | negative regulation of T cell mediated immunity |
| GO:0046641 | 0.01016 | 5.50987 | 1 | 4 | 19 | positive regulation of alpha-beta T cell proliferation |
| GO:0060004 | 0.01016 | 5.50987 | 1 | 4 | 19 | reflex |
| GO:0001704 | 0.01040 | 2.28392 | 6 | 12 | 121 | formation of primary germ layer |
| GO:1903317 | 0.01065 | 2.00253 | 8 | 16 | 182 | regulation of protein maturation |
| GO:0001909 | 0.01073 | 2.37606 | 5 | 11 | 107 | leukocyte mediated cytotoxicity |
| GO:0051704 | 0.01080 | 1.24952 | 122 | 146 | 2635 | multi-organism process |
| GO:0031099 | 0.01080 | 1.95200 | 9 | 17 | 198 | regeneration |
| GO:1901655 | 0.01085 | 2.49729 | 4 | 10 | 93 | cellular response to ketone |
| GO:0150077 | 0.01093 | 3.54632 | 2 | 6 | 41 | regulation of neuroinflammatory response |
| GO:0032496 | 0.01117 | 1.70765 | 15 | 25 | 330 | response to lipopolysaccharide |
| GO:0031349 | 0.01120 | 1.55079 | 24 | 36 | 521 | positive regulation of defense response |
| GO:0050869 | 0.01147 | 4.13488 | 1 | 5 | 30 | negative regulation of B cell activation |
| GO:0050673 | 0.01152 | 1.60505 | 20 | 31 | 434 | epithelial cell proliferation |
| GO:0051051 | 0.01152 | 1.54751 | 24 | 36 | 522 | negative regulation of transport |
| GO:0030030 | 0.01152 | 1.31578 | 71 | 90 | 1534 | cell projection organization |
| GO:0030162 | 0.01154 | 1.42849 | 39 | 53 | 831 | regulation of proteolysis |
| GO:0030168 | 0.01173 | 2.09085 | 7 | 14 | 153 | platelet activation |
| GO:0062013 | 0.01173 | 2.09085 | 7 | 14 | 153 | positive regulation of small molecule metabolic process |
| GO:0000075 | 0.01187 | 1.88977 | 10 | 18 | 216 | cell cycle checkpoint |
| GO:0002699 | 0.01187 | 1.88977 | 10 | 18 | 216 | positive regulation of immune effector process |
| GO:0007091 | 0.01188 | 3.08253 | 3 | 7 | 54 | metaphase/anaphase transition of mitotic cell cycle |
| GO:0070206 | 0.01188 | 3.08253 | 3 | 7 | 54 | protein trimerization |
| GO:0051962 | 0.01190 | 1.53395 | 25 | 37 | 541 | positive regulation of nervous system development |
| GO:0050909 | 0.01196 | 2.80774 | 3 | 8 | 67 | sensory perception of taste |
| GO:0002282 | 0.01209 | 20.62920 | 0 | 2 | 4 | microglial cell activation involved in immune response |
| GO:0007598 | 0.01209 | 20.62920 | 0 | 2 | 4 | blood coagulation, extrinsic pathway |
| GO:0009753 | 0.01209 | 20.62920 | 0 | 2 | 4 | response to jasmonic acid |
| GO:0019805 | 0.01209 | 20.62920 | 0 | 2 | 4 | quinolinate biosynthetic process |
| GO:0032571 | 0.01209 | 20.62920 | 0 | 2 | 4 | response to vitamin K |
| GO:0035788 | 0.01209 | 20.62920 | 0 | 2 | 4 | cell migration involved in metanephros development |
| GO:0035789 | 0.01209 | 20.62920 | 0 | 2 | 4 | metanephric mesenchymal cell migration |
| GO:0036146 | 0.01209 | 20.62920 | 0 | 2 | 4 | cellular response to mycotoxin |
| GO:0042253 | 0.01209 | 20.62920 | 0 | 2 | 4 | granulocyte macrophage colony-stimulating factor biosynthetic process |
| GO:0042483 | 0.01209 | 20.62920 | 0 | 2 | 4 | negative regulation of odontogenesis |
| GO:0045082 | 0.01209 | 20.62920 | 0 | 2 | 4 | positive regulation of interleukin-10 biosynthetic process |
| GO:0045914 | 0.01209 | 20.62920 | 0 | 2 | 4 | negative regulation of catecholamine metabolic process |
| GO:0045963 | 0.01209 | 20.62920 | 0 | 2 | 4 | negative regulation of dopamine metabolic process |
| GO:0060160 | 0.01209 | 20.62920 | 0 | 2 | 4 | negative regulation of dopamine receptor signaling pathway |
| GO:0060282 | 0.01209 | 20.62920 | 0 | 2 | 4 | positive regulation of oocyte development |
| GO:0060535 | 0.01209 | 20.62920 | 0 | 2 | 4 | trachea cartilage morphogenesis |
| GO:0060686 | 0.01209 | 20.62920 | 0 | 2 | 4 | negative regulation of prostatic bud formation |
| GO:0061642 | 0.01209 | 20.62920 | 0 | 2 | 4 | chemoattraction of axon |
| GO:0071395 | 0.01209 | 20.62920 | 0 | 2 | 4 | cellular response to jasmonic acid stimulus |
| GO:0097118 | 0.01209 | 20.62920 | 0 | 2 | 4 | neuroligin clustering involved in postsynaptic membrane assembly |
| GO:0110088 | 0.01209 | 20.62920 | 0 | 2 | 4 | hippocampal neuron apoptotic process |
| GO:0110089 | 0.01209 | 20.62920 | 0 | 2 | 4 | regulation of hippocampal neuron apoptotic process |
| GO:1902731 | 0.01209 | 20.62920 | 0 | 2 | 4 | negative regulation of chondrocyte proliferation |
| GO:1905881 | 0.01209 | 20.62920 | 0 | 2 | 4 | positive regulation of oogenesis |
| GO:1990523 | 0.01209 | 20.62920 | 0 | 2 | 4 | bone regeneration |
| GO:2000589 | 0.01209 | 20.62920 | 0 | 2 | 4 | regulation of metanephric mesenchymal cell migration |
| GO:2001206 | 0.01209 | 20.62920 | 0 | 2 | 4 | positive regulation of osteoclast development |
| GO:0006915 | 0.01223 | 1.27666 | 92 | 113 | 1988 | apoptotic process |
| GO:0090195 | 0.01224 | 5.16521 | 1 | 4 | 20 | chemokine secretion |
| GO:1903978 | 0.01224 | 5.16521 | 1 | 4 | 20 | regulation of microglial cell activation |
| GO:0015701 | 0.01226 | 3.44761 | 2 | 6 | 42 | bicarbonate transport |
| GO:0032958 | 0.01226 | 3.44761 | 2 | 6 | 42 | inositol phosphate biosynthetic process |
| GO:0033048 | 0.01226 | 3.44761 | 2 | 6 | 42 | negative regulation of mitotic sister chromatid segregation |
| GO:1903708 | 0.01232 | 1.96664 | 9 | 16 | 185 | positive regulation of hemopoiesis |
| GO:0016264 | 0.01237 | 7.74231 | 1 | 3 | 11 | gap junction assembly |
| GO:0019371 | 0.01237 | 7.74231 | 1 | 3 | 11 | cyclooxygenase pathway |
| GO:0031652 | 0.01237 | 7.74231 | 1 | 3 | 11 | positive regulation of heat generation |
| GO:0035404 | 0.01237 | 7.74231 | 1 | 3 | 11 | histone-serine phosphorylation |
| GO:0045060 | 0.01237 | 7.74231 | 1 | 3 | 11 | negative thymic T cell selection |
| GO:0051583 | 0.01237 | 7.74231 | 1 | 3 | 11 | dopamine uptake involved in synaptic transmission |
| GO:0051934 | 0.01237 | 7.74231 | 1 | 3 | 11 | catecholamine uptake involved in synaptic transmission |
| GO:0051974 | 0.01237 | 7.74231 | 1 | 3 | 11 | negative regulation of telomerase activity |
| GO:0060174 | 0.01237 | 7.74231 | 1 | 3 | 11 | limb bud formation |
| GO:0070189 | 0.01237 | 7.74231 | 1 | 3 | 11 | kynurenine metabolic process |
| GO:0090193 | 0.01237 | 7.74231 | 1 | 3 | 11 | positive regulation of glomerulus development |
| GO:1903980 | 0.01237 | 7.74231 | 1 | 3 | 11 | positive regulation of microglial cell activation |
| GO:1904468 | 0.01237 | 7.74231 | 1 | 3 | 11 | negative regulation of tumor necrosis factor secretion |
| GO:1905383 | 0.01237 | 7.74231 | 1 | 3 | 11 | protein localization to presynapse |
| GO:2001204 | 0.01237 | 7.74231 | 1 | 3 | 11 | regulation of osteoclast development |
| GO:0015849 | 0.01240 | 1.69073 | 15 | 25 | 333 | organic acid transport |
| GO:0046942 | 0.01240 | 1.69073 | 15 | 25 | 333 | carboxylic acid transport |
| GO:0071804 | 0.01240 | 1.88017 | 10 | 18 | 217 | cellular potassium ion transport |
| GO:0071805 | 0.01240 | 1.88017 | 10 | 18 | 217 | potassium ion transmembrane transport |
| GO:0044070 | 0.01250 | 2.43825 | 4 | 10 | 95 | regulation of anion transport |
| GO:0048545 | 0.01267 | 1.63497 | 18 | 28 | 385 | response to steroid hormone |
| GO:0050790 | 0.01271 | 1.25588 | 108 | 130 | 2328 | regulation of catalytic activity |
| GO:0007051 | 0.01273 | 2.00949 | 8 | 15 | 170 | spindle organization |
| GO:0070372 | 0.01275 | 1.72850 | 14 | 23 | 300 | regulation of ERK1 and ERK2 cascade |
| GO:0070371 | 0.01282 | 1.70562 | 15 | 24 | 317 | ERK1 and ERK2 cascade |
| GO:0071902 | 0.01284 | 1.68516 | 15 | 25 | 334 | positive regulation of protein serine/threonine kinase activity |
| GO:0048588 | 0.01284 | 1.83743 | 11 | 19 | 234 | developmental cell growth |
| GO:0010001 | 0.01296 | 1.87066 | 10 | 18 | 218 | glial cell differentiation |
| GO:0006508 | 0.01298 | 1.28123 | 87 | 107 | 1874 | proteolysis |
| GO:0031343 | 0.01302 | 2.76079 | 3 | 8 | 68 | positive regulation of cell killing |
| GO:0050918 | 0.01302 | 2.76079 | 3 | 8 | 68 | positive chemotaxis |
| GO:0006024 | 0.01304 | 2.30367 | 5 | 11 | 110 | glycosaminoglycan biosynthetic process |
| GO:0044380 | 0.01309 | 3.01814 | 3 | 7 | 55 | protein localization to cytoskeleton |
| GO:0072593 | 0.01310 | 1.74742 | 13 | 22 | 284 | reactive oxygen species metabolic process |
| GO:0002888 | 0.01316 | 3.97563 | 1 | 5 | 31 | positive regulation of myeloid leukocyte mediated immunity |
| GO:1904951 | 0.01316 | 1.57476 | 21 | 32 | 456 | positive regulation of establishment of protein localization |
| GO:0035725 | 0.01324 | 2.12390 | 6 | 13 | 140 | sodium ion transmembrane transport |
| GO:0042737 | 0.01324 | 2.12390 | 6 | 13 | 140 | drug catabolic process |
| GO:0060078 | 0.01324 | 2.12390 | 6 | 13 | 140 | regulation of postsynaptic membrane potential |
| GO:0000910 | 0.01337 | 1.99649 | 8 | 15 | 171 | cytokinesis |
| GO:0030279 | 0.01345 | 2.55390 | 4 | 9 | 82 | negative regulation of ossification |
| GO:0007584 | 0.01353 | 1.86125 | 10 | 18 | 219 | response to nutrient |
| GO:0006692 | 0.01371 | 3.35425 | 2 | 6 | 43 | prostanoid metabolic process |
| GO:0006693 | 0.01371 | 3.35425 | 2 | 6 | 43 | prostaglandin metabolic process |
| GO:0048589 | 0.01402 | 1.46105 | 31 | 44 | 674 | developmental growth |
| GO:0030166 | 0.01415 | 2.71538 | 3 | 8 | 69 | proteoglycan biosynthetic process |
| GO:0051338 | 0.01423 | 1.38060 | 45 | 60 | 972 | regulation of transferase activity |
| GO:0007423 | 0.01433 | 1.51233 | 25 | 37 | 548 | sensory organ development |
| GO:0042981 | 0.01436 | 1.29844 | 74 | 92 | 1587 | regulation of apoptotic process |
| GO:0031295 | 0.01438 | 2.95638 | 3 | 7 | 56 | T cell costimulation |
| GO:0090307 | 0.01438 | 2.95638 | 3 | 7 | 56 | mitotic spindle assembly |
| GO:0071495 | 0.01441 | 1.31758 | 65 | 82 | 1393 | cellular response to endogenous stimulus |
| GO:0030509 | 0.01447 | 2.03190 | 7 | 14 | 157 | BMP signaling pathway |
| GO:1905952 | 0.01447 | 2.03190 | 7 | 14 | 157 | regulation of lipid localization |
| GO:0002438 | 0.01458 | 4.86111 | 1 | 4 | 21 | acute inflammatory response to antigenic stimulus |
| GO:0051383 | 0.01458 | 4.86111 | 1 | 4 | 21 | kinetochore organization |
| GO:0060713 | 0.01458 | 4.86111 | 1 | 4 | 21 | labyrinthine layer morphogenesis |
| GO:0090280 | 0.01458 | 4.86111 | 1 | 4 | 21 | positive regulation of calcium ion import |
| GO:0140131 | 0.01458 | 4.86111 | 1 | 4 | 21 | positive regulation of lymphocyte chemotaxis |
| GO:0022402 | 0.01464 | 1.31649 | 65 | 82 | 1394 | cell cycle process |
| GO:0043279 | 0.01478 | 2.25780 | 5 | 11 | 112 | response to alkaloid |
| GO:0051924 | 0.01484 | 1.77727 | 12 | 20 | 254 | regulation of calcium ion transport |
| GO:0055094 | 0.01502 | 3.82817 | 1 | 5 | 32 | response to lipoprotein particle |
| GO:0060325 | 0.01502 | 3.82817 | 1 | 5 | 32 | face morphogenesis |
| GO:0071295 | 0.01502 | 3.82817 | 1 | 5 | 32 | cellular response to vitamin |
| GO:1904467 | 0.01502 | 3.82817 | 1 | 5 | 32 | regulation of tumor necrosis factor secretion |
| GO:0002250 | 0.01504 | 1.45387 | 31 | 44 | 677 | adaptive immune response |
| GO:0048598 | 0.01506 | 1.48966 | 27 | 39 | 586 | embryonic morphogenesis |
| GO:0045860 | 0.01508 | 1.51544 | 25 | 36 | 532 | positive regulation of protein kinase activity |
| GO:0006959 | 0.01512 | 1.64102 | 16 | 26 | 356 | humoral immune response |
| GO:0014002 | 0.01527 | 3.26579 | 2 | 6 | 44 | astrocyte development |
| GO:0030225 | 0.01527 | 3.26579 | 2 | 6 | 44 | macrophage differentiation |
| GO:0033046 | 0.01527 | 3.26579 | 2 | 6 | 44 | negative regulation of sister chromatid segregation |
| GO:0035850 | 0.01527 | 3.26579 | 2 | 6 | 44 | epithelial cell differentiation involved in kidney development |
| GO:0090382 | 0.01527 | 3.26579 | 2 | 6 | 44 | phagosome maturation |
| GO:0031399 | 0.01554 | 1.27238 | 86 | 106 | 1867 | regulation of protein modification process |
| GO:0023061 | 0.01563 | 1.55225 | 21 | 32 | 462 | signal release |
| GO:0010965 | 0.01575 | 2.89709 | 3 | 7 | 57 | regulation of mitotic sister chromatid separation |
| GO:0031294 | 0.01575 | 2.89709 | 3 | 7 | 57 | lymphocyte costimulation |
| GO:2000272 | 0.01575 | 2.89709 | 3 | 7 | 57 | negative regulation of signaling receptor activity |
| GO:0043067 | 0.01584 | 1.29065 | 75 | 93 | 1613 | regulation of programmed cell death |
| GO:0002863 | 0.01593 | 6.88167 | 1 | 3 | 12 | positive regulation of inflammatory response to antigenic stimulus |
| GO:0006568 | 0.01593 | 6.88167 | 1 | 3 | 12 | tryptophan metabolic process |
| GO:0014831 | 0.01593 | 6.88167 | 1 | 3 | 12 | gastro-intestinal system smooth muscle contraction |
| GO:0030157 | 0.01593 | 6.88167 | 1 | 3 | 12 | pancreatic juice secretion |
| GO:0033197 | 0.01593 | 6.88167 | 1 | 3 | 12 | response to vitamin E |
| GO:0042340 | 0.01593 | 6.88167 | 1 | 3 | 12 | keratan sulfate catabolic process |
| GO:0043383 | 0.01593 | 6.88167 | 1 | 3 | 12 | negative T cell selection |
| GO:0043696 | 0.01593 | 6.88167 | 1 | 3 | 12 | dedifferentiation |
| GO:0043697 | 0.01593 | 6.88167 | 1 | 3 | 12 | cell dedifferentiation |
| GO:0043922 | 0.01593 | 6.88167 | 1 | 3 | 12 | negative regulation by host of viral transcription |
| GO:0045416 | 0.01593 | 6.88167 | 1 | 3 | 12 | positive regulation of interleukin-8 biosynthetic process |
| GO:0046541 | 0.01593 | 6.88167 | 1 | 3 | 12 | saliva secretion |
| GO:0048302 | 0.01593 | 6.88167 | 1 | 3 | 12 | regulation of isotype switching to IgG isotypes |
| GO:0060707 | 0.01593 | 6.88167 | 1 | 3 | 12 | trophoblast giant cell differentiation |
| GO:0060900 | 0.01593 | 6.88167 | 1 | 3 | 12 | embryonic camera-type eye formation |
| GO:0070601 | 0.01593 | 6.88167 | 1 | 3 | 12 | centromeric sister chromatid cohesion |
| GO:0097104 | 0.01593 | 6.88167 | 1 | 3 | 12 | postsynaptic membrane assembly |
| GO:0099550 | 0.01593 | 6.88167 | 1 | 3 | 12 | trans-synaptic signaling, modulating synaptic transmission |
| GO:0099640 | 0.01593 | 6.88167 | 1 | 3 | 12 | axo-dendritic protein transport |
| GO:1902950 | 0.01593 | 6.88167 | 1 | 3 | 12 | regulation of dendritic spine maintenance |
| GO:2001223 | 0.01593 | 6.88167 | 1 | 3 | 12 | negative regulation of neuron migration |
| GO:0050730 | 0.01603 | 1.76201 | 12 | 20 | 256 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0090596 | 0.01603 | 1.76201 | 12 | 20 | 256 | sensory organ morphogenesis |
| GO:0048568 | 0.01623 | 1.57136 | 20 | 30 | 428 | embryonic organ development |
| GO:0010720 | 0.01630 | 1.49724 | 26 | 37 | 553 | positive regulation of cell development |
| GO:0070848 | 0.01637 | 1.42734 | 34 | 47 | 736 | response to growth factor |
| GO:0030217 | 0.01639 | 1.78693 | 11 | 19 | 240 | T cell differentiation |
| GO:0071482 | 0.01668 | 2.12679 | 6 | 12 | 129 | cellular response to light stimulus |
| GO:0051985 | 0.01695 | 3.18188 | 2 | 6 | 45 | negative regulation of chromosome segregation |
| GO:0050731 | 0.01702 | 1.88768 | 9 | 16 | 192 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0001914 | 0.01704 | 3.69124 | 2 | 5 | 33 | regulation of T cell mediated cytotoxicity |
| GO:0032633 | 0.01704 | 3.69124 | 2 | 5 | 33 | interleukin-4 production |
| GO:0046633 | 0.01704 | 3.69124 | 2 | 5 | 33 | alpha-beta T cell proliferation |
| GO:0099084 | 0.01704 | 3.69124 | 2 | 5 | 33 | postsynaptic specialization organization |
| GO:0023057 | 0.01707 | 1.30415 | 66 | 83 | 1423 | negative regulation of signaling |
| GO:0012501 | 0.01715 | 1.25142 | 99 | 119 | 2132 | programmed cell death |
| GO:0016055 | 0.01716 | 1.50910 | 24 | 35 | 519 | Wnt signaling pathway |
| GO:0010155 | 0.01718 | 4.59079 | 1 | 4 | 22 | regulation of proton transport |
| GO:0071379 | 0.01718 | 4.59079 | 1 | 4 | 22 | cellular response to prostaglandin stimulus |
| GO:0043406 | 0.01730 | 1.74700 | 12 | 20 | 258 | positive regulation of MAP kinase activity |
| GO:0043085 | 0.01734 | 1.30310 | 66 | 83 | 1424 | positive regulation of catalytic activity |
| GO:0030301 | 0.01746 | 2.30214 | 5 | 10 | 100 | cholesterol transport |
| GO:0061640 | 0.01746 | 2.30214 | 5 | 10 | 100 | cytoskeleton-dependent cytokinesis |
| GO:0006023 | 0.01771 | 2.19230 | 5 | 11 | 115 | aminoglycan biosynthetic process |
| GO:0060291 | 0.01795 | 2.42068 | 4 | 9 | 86 | long-term synaptic potentiation |
| GO:1901699 | 0.01796 | 1.44837 | 30 | 42 | 648 | cellular response to nitrogen compound |
| GO:0198738 | 0.01808 | 1.50271 | 24 | 35 | 521 | cell-cell signaling by wnt |
| GO:0007010 | 0.01818 | 1.31036 | 62 | 78 | 1330 | cytoskeleton organization |
| GO:0001654 | 0.01830 | 1.61117 | 17 | 26 | 362 | eye development |
| GO:0009612 | 0.01840 | 1.82938 | 10 | 17 | 210 | response to mechanical stimulus |
| GO:0015718 | 0.01854 | 1.96270 | 8 | 14 | 162 | monocarboxylic acid transport |
| GO:0046632 | 0.01860 | 2.27672 | 5 | 10 | 101 | alpha-beta T cell differentiation |
| GO:0048661 | 0.01860 | 2.27672 | 5 | 10 | 101 | positive regulation of smooth muscle cell proliferation |
| GO:0001504 | 0.01875 | 3.10215 | 2 | 6 | 46 | neurotransmitter uptake |
| GO:0032732 | 0.01879 | 2.78535 | 3 | 7 | 59 | positive regulation of interleukin-1 production |
| GO:0042130 | 0.01879 | 2.78535 | 3 | 7 | 59 | negative regulation of T cell proliferation |
| GO:0045861 | 0.01888 | 1.60629 | 17 | 26 | 363 | negative regulation of proteolysis |
| GO:0030099 | 0.01910 | 1.56127 | 19 | 29 | 416 | myeloid cell differentiation |
| GO:0010574 | 0.01924 | 3.56375 | 2 | 5 | 34 | regulation of vascular endothelial growth factor production |
| GO:0019228 | 0.01924 | 3.56375 | 2 | 5 | 34 | neuronal action potential |
| GO:0071402 | 0.01924 | 3.56375 | 2 | 5 | 34 | cellular response to lipoprotein particle stimulus |
| GO:0000281 | 0.01939 | 2.54771 | 3 | 8 | 73 | mitotic cytokinesis |
| GO:0052547 | 0.01939 | 1.53484 | 21 | 31 | 452 | regulation of peptidase activity |
| GO:0050768 | 0.01946 | 1.67596 | 14 | 22 | 295 | negative regulation of neurogenesis |
| GO:0048736 | 0.01952 | 1.89824 | 8 | 15 | 179 | appendage development |
| GO:0060173 | 0.01952 | 1.89824 | 8 | 15 | 179 | limb development |
| GO:0002501 | 0.01953 | 13.75203 | 0 | 2 | 5 | peptide antigen assembly with MHC protein complex |
| GO:0006710 | 0.01953 | 13.75203 | 0 | 2 | 5 | androgen catabolic process |
| GO:0010716 | 0.01953 | 13.75203 | 0 | 2 | 5 | negative regulation of extracellular matrix disassembly |
| GO:0019441 | 0.01953 | 13.75203 | 0 | 2 | 5 | tryptophan catabolic process to kynurenine |
| GO:0030263 | 0.01953 | 13.75203 | 0 | 2 | 5 | apoptotic chromosome condensation |
| GO:0031580 | 0.01953 | 13.75203 | 0 | 2 | 5 | membrane raft distribution |
| GO:0034239 | 0.01953 | 13.75203 | 0 | 2 | 5 | regulation of macrophage fusion |
| GO:0034241 | 0.01953 | 13.75203 | 0 | 2 | 5 | positive regulation of macrophage fusion |
| GO:0035470 | 0.01953 | 13.75203 | 0 | 2 | 5 | positive regulation of vascular wound healing |
| GO:0035787 | 0.01953 | 13.75203 | 0 | 2 | 5 | cell migration involved in kidney development |
| GO:0045586 | 0.01953 | 13.75203 | 0 | 2 | 5 | regulation of gamma-delta T cell differentiation |
| GO:0046874 | 0.01953 | 13.75203 | 0 | 2 | 5 | quinolinate metabolic process |
| GO:0051754 | 0.01953 | 13.75203 | 0 | 2 | 5 | meiotic sister chromatid cohesion, centromeric |
| GO:0060392 | 0.01953 | 13.75203 | 0 | 2 | 5 | negative regulation of SMAD protein signal transduction |
| GO:0060666 | 0.01953 | 13.75203 | 0 | 2 | 5 | dichotomous subdivision of terminal units involved in salivary gland branching |
| GO:0070173 | 0.01953 | 13.75203 | 0 | 2 | 5 | regulation of enamel mineralization |
| GO:0071798 | 0.01953 | 13.75203 | 0 | 2 | 5 | response to prostaglandin D |
| GO:0071799 | 0.01953 | 13.75203 | 0 | 2 | 5 | cellular response to prostaglandin D stimulus |
| GO:0072300 | 0.01953 | 13.75203 | 0 | 2 | 5 | positive regulation of metanephric glomerulus development |
| GO:0098937 | 0.01953 | 13.75203 | 0 | 2 | 5 | anterograde dendritic transport |
| GO:1901490 | 0.01953 | 13.75203 | 0 | 2 | 5 | regulation of lymphangiogenesis |
| GO:1902714 | 0.01953 | 13.75203 | 0 | 2 | 5 | negative regulation of interferon-gamma secretion |
| GO:1904141 | 0.01953 | 13.75203 | 0 | 2 | 5 | positive regulation of microglial cell migration |
| GO:2000467 | 0.01953 | 13.75203 | 0 | 2 | 5 | positive regulation of glycogen (starch) synthase activity |
| GO:2000646 | 0.01953 | 13.75203 | 0 | 2 | 5 | positive regulation of receptor catabolic process |
| GO:0000079 | 0.01980 | 2.25184 | 5 | 10 | 102 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0071219 | 0.01999 | 1.81041 | 10 | 17 | 212 | cellular response to molecule of bacterial origin |
| GO:0002864 | 0.02001 | 6.19316 | 1 | 3 | 13 | regulation of acute inflammatory response to antigenic stimulus |
| GO:0005513 | 0.02001 | 6.19316 | 1 | 3 | 13 | detection of calcium ion |
| GO:0031650 | 0.02001 | 6.19316 | 1 | 3 | 13 | regulation of heat generation |
| GO:0031953 | 0.02001 | 6.19316 | 1 | 3 | 13 | negative regulation of protein autophosphorylation |
| GO:0045078 | 0.02001 | 6.19316 | 1 | 3 | 13 | positive regulation of interferon-gamma biosynthetic process |
| GO:0048291 | 0.02001 | 6.19316 | 1 | 3 | 13 | isotype switching to IgG isotypes |
| GO:0060100 | 0.02001 | 6.19316 | 1 | 3 | 13 | positive regulation of phagocytosis, engulfment |
| GO:0061430 | 0.02001 | 6.19316 | 1 | 3 | 13 | bone trabecula morphogenesis |
| GO:0090677 | 0.02001 | 6.19316 | 1 | 3 | 13 | reversible differentiation |
| GO:1905155 | 0.02001 | 6.19316 | 1 | 3 | 13 | positive regulation of membrane invagination |
| GO:0032373 | 0.02005 | 4.34892 | 1 | 4 | 23 | positive regulation of sterol transport |
| GO:0032376 | 0.02005 | 4.34892 | 1 | 4 | 23 | positive regulation of cholesterol transport |
| GO:0032753 | 0.02005 | 4.34892 | 1 | 4 | 23 | positive regulation of interleukin-4 production |
| GO:0032799 | 0.02005 | 4.34892 | 1 | 4 | 23 | low-density lipoprotein receptor particle metabolic process |
| GO:0036037 | 0.02005 | 4.34892 | 1 | 4 | 23 | CD8-positive, alpha-beta T cell activation |
| GO:0051589 | 0.02005 | 4.34892 | 1 | 4 | 23 | negative regulation of neurotransmitter transport |
| GO:1901214 | 0.02005 | 1.64979 | 15 | 23 | 313 | regulation of neuron death |
| GO:0010466 | 0.02008 | 1.71774 | 12 | 20 | 262 | negative regulation of peptidase activity |
| GO:0035107 | 0.02016 | 1.99713 | 7 | 13 | 148 | appendage morphogenesis |
| GO:0035108 | 0.02016 | 1.99713 | 7 | 13 | 148 | limb morphogenesis |
| GO:0045576 | 0.02044 | 2.73264 | 3 | 7 | 60 | mast cell activation |
| GO:0051306 | 0.02044 | 2.73264 | 3 | 7 | 60 | mitotic sister chromatid separation |
| GO:0051128 | 0.02050 | 1.22560 | 116 | 137 | 2507 | regulation of cellular component organization |
| GO:0070098 | 0.02057 | 2.35913 | 4 | 9 | 88 | chemokine-mediated signaling pathway |
| GO:0006953 | 0.02068 | 3.02632 | 2 | 6 | 47 | acute-phase response |
| GO:0014911 | 0.02068 | 3.02632 | 2 | 6 | 47 | positive regulation of smooth muscle cell migration |
| GO:0030261 | 0.02068 | 3.02632 | 2 | 6 | 47 | chromosome condensation |
| GO:0070169 | 0.02068 | 3.02632 | 2 | 6 | 47 | positive regulation of biomineral tissue development |
| GO:0009416 | 0.02073 | 1.64402 | 15 | 23 | 314 | response to light stimulus |
| GO:0050767 | 0.02080 | 1.38423 | 38 | 51 | 822 | regulation of neurogenesis |
| GO:0043507 | 0.02088 | 2.50896 | 3 | 8 | 74 | positive regulation of JUN kinase activity |
| GO:0099601 | 0.02088 | 2.50896 | 3 | 8 | 74 | regulation of neurotransmitter receptor activity |
| GO:0007229 | 0.02105 | 2.22750 | 5 | 10 | 103 | integrin-mediated signaling pathway |
| GO:0002706 | 0.02119 | 1.98233 | 7 | 13 | 149 | regulation of lymphocyte mediated immunity |
| GO:0051961 | 0.02142 | 1.63830 | 15 | 23 | 315 | negative regulation of nervous system development |
| GO:0098801 | 0.02162 | 3.44477 | 2 | 5 | 35 | regulation of renal system process |
| GO:1990774 | 0.02162 | 3.44477 | 2 | 5 | 35 | tumor necrosis factor secretion |
| GO:0010648 | 0.02166 | 1.28992 | 66 | 82 | 1419 | negative regulation of cell communication |
| GO:0019538 | 0.02197 | 1.16234 | 277 | 305 | 5986 | protein metabolic process |
| GO:0000226 | 0.02204 | 1.46968 | 25 | 36 | 547 | microtubule cytoskeleton organization |
| GO:0060541 | 0.02206 | 1.82482 | 9 | 16 | 198 | respiratory system development |
| GO:0006898 | 0.02213 | 1.63262 | 15 | 23 | 316 | receptor-mediated endocytosis |
| GO:0034113 | 0.02220 | 2.68188 | 3 | 7 | 61 | heterotypic cell-cell adhesion |
| GO:0045123 | 0.02220 | 2.68188 | 3 | 7 | 61 | cellular extravasation |
| GO:0090303 | 0.02220 | 2.68188 | 3 | 7 | 61 | positive regulation of wound healing |
| GO:0019884 | 0.02231 | 1.86383 | 8 | 15 | 182 | antigen processing and presentation of exogenous antigen |
| GO:0001960 | 0.02246 | 2.47138 | 3 | 8 | 75 | negative regulation of cytokine-mediated signaling pathway |
| GO:0007422 | 0.02246 | 2.47138 | 3 | 8 | 75 | peripheral nervous system development |
| GO:0070374 | 0.02257 | 1.78268 | 10 | 17 | 215 | positive regulation of ERK1 and ERK2 cascade |
| GO:0046850 | 0.02273 | 2.95410 | 2 | 6 | 48 | regulation of bone remodeling |
| GO:0051972 | 0.02273 | 2.95410 | 2 | 6 | 48 | regulation of telomerase activity |
| GO:0060324 | 0.02273 | 2.95410 | 2 | 6 | 48 | face development |
| GO:0072604 | 0.02273 | 2.95410 | 2 | 6 | 48 | interleukin-6 secretion |
| GO:0010324 | 0.02300 | 2.02236 | 6 | 12 | 135 | membrane invagination |
| GO:0043900 | 0.02313 | 1.54646 | 19 | 28 | 405 | regulation of multi-organism process |
| GO:0002407 | 0.02320 | 4.13124 | 1 | 4 | 24 | dendritic cell chemotaxis |
| GO:0002861 | 0.02320 | 4.13124 | 1 | 4 | 24 | regulation of inflammatory response to antigenic stimulus |
| GO:0042104 | 0.02320 | 4.13124 | 1 | 4 | 24 | positive regulation of activated T cell proliferation |
| GO:0042430 | 0.02320 | 4.13124 | 1 | 4 | 24 | indole-containing compound metabolic process |
| GO:0043302 | 0.02320 | 4.13124 | 1 | 4 | 24 | positive regulation of leukocyte degranulation |
| GO:0046135 | 0.02320 | 4.13124 | 1 | 4 | 24 | pyrimidine nucleoside catabolic process |
| GO:1901071 | 0.02320 | 4.13124 | 1 | 4 | 24 | glucosamine-containing compound metabolic process |
| GO:1902547 | 0.02320 | 4.13124 | 1 | 4 | 24 | regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:1903010 | 0.02320 | 4.13124 | 1 | 4 | 24 | regulation of bone development |
| GO:0060070 | 0.02334 | 1.60525 | 16 | 24 | 335 | canonical Wnt signaling pathway |
| GO:0032651 | 0.02345 | 2.30062 | 4 | 9 | 90 | regulation of interleukin-1 beta production |
| GO:0002698 | 0.02352 | 2.09114 | 6 | 11 | 120 | negative regulation of immune effector process |
| GO:0032835 | 0.02406 | 2.63297 | 3 | 7 | 62 | glomerulus development |
| GO:0045453 | 0.02406 | 2.63297 | 3 | 7 | 62 | bone resorption |
| GO:0046635 | 0.02406 | 2.63297 | 3 | 7 | 62 | positive regulation of alpha-beta T cell activation |
| GO:0061045 | 0.02412 | 2.43490 | 4 | 8 | 76 | negative regulation of wound healing |
| GO:0010573 | 0.02417 | 3.33346 | 2 | 5 | 36 | vascular endothelial growth factor production |
| GO:0030224 | 0.02417 | 3.33346 | 2 | 5 | 36 | monocyte differentiation |
| GO:0032733 | 0.02417 | 3.33346 | 2 | 5 | 36 | positive regulation of interleukin-10 production |
| GO:1903131 | 0.02417 | 3.33346 | 2 | 5 | 36 | mononuclear cell differentiation |
| GO:0007292 | 0.02420 | 2.00594 | 6 | 12 | 136 | female gamete generation |
| GO:0009582 | 0.02420 | 2.00594 | 6 | 12 | 136 | detection of abiotic stimulus |
| GO:0031589 | 0.02445 | 1.58091 | 16 | 25 | 354 | cell-substrate adhesion |
| GO:0000187 | 0.02451 | 1.93922 | 7 | 13 | 152 | activation of MAPK activity |
| GO:0052548 | 0.02459 | 1.52500 | 20 | 29 | 425 | regulation of endopeptidase activity |
| GO:0042487 | 0.02460 | 5.62982 | 1 | 3 | 14 | regulation of odontogenesis of dentin-containing tooth |
| GO:0043374 | 0.02460 | 5.62982 | 1 | 3 | 14 | CD8-positive, alpha-beta T cell differentiation |
| GO:0045836 | 0.02460 | 5.62982 | 1 | 3 | 14 | positive regulation of meiotic nuclear division |
| GO:0046629 | 0.02460 | 5.62982 | 1 | 3 | 14 | gamma-delta T cell activation |
| GO:0060732 | 0.02460 | 5.62982 | 1 | 3 | 14 | positive regulation of inositol phosphate biosynthetic process |
| GO:1900121 | 0.02460 | 5.62982 | 1 | 3 | 14 | negative regulation of receptor binding |
| GO:1903054 | 0.02460 | 5.62982 | 1 | 3 | 14 | negative regulation of extracellular matrix organization |
| GO:1905064 | 0.02460 | 5.62982 | 1 | 3 | 14 | negative regulation of vascular smooth muscle cell differentiation |
| GO:0043405 | 0.02483 | 1.59482 | 16 | 24 | 337 | regulation of MAP kinase activity |
| GO:0002686 | 0.02492 | 2.88524 | 2 | 6 | 49 | negative regulation of leukocyte migration |
| GO:0003044 | 0.02492 | 2.88524 | 2 | 6 | 49 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0032757 | 0.02492 | 2.88524 | 2 | 6 | 49 | positive regulation of interleukin-8 production |
| GO:1904707 | 0.02492 | 2.88524 | 2 | 6 | 49 | positive regulation of vascular smooth muscle cell proliferation |
| GO:0060333 | 0.02499 | 2.27244 | 4 | 9 | 91 | interferon-gamma-mediated signaling pathway |
| GO:1904029 | 0.02515 | 2.15753 | 5 | 10 | 106 | regulation of cyclin-dependent protein kinase activity |
| GO:1901987 | 0.02531 | 1.48834 | 22 | 32 | 480 | regulation of cell cycle phase transition |
| GO:0015698 | 0.02565 | 1.87332 | 8 | 14 | 169 | inorganic anion transport |
| GO:0060560 | 0.02565 | 1.72245 | 11 | 18 | 235 | developmental growth involved in morphogenesis |
| GO:0050852 | 0.02600 | 1.78517 | 9 | 16 | 202 | T cell receptor signaling pathway |
| GO:0031646 | 0.02603 | 2.58581 | 3 | 7 | 63 | positive regulation of neurological system process |
| GO:0003309 | 0.02664 | 3.93430 | 1 | 4 | 25 | type B pancreatic cell differentiation |
| GO:0045672 | 0.02664 | 3.93430 | 1 | 4 | 25 | positive regulation of osteoclast differentiation |
| GO:0045956 | 0.02664 | 3.93430 | 1 | 4 | 25 | positive regulation of calcium ion-dependent exocytosis |
| GO:0050927 | 0.02664 | 3.93430 | 1 | 4 | 25 | positive regulation of positive chemotaxis |
| GO:0051307 | 0.02664 | 3.93430 | 1 | 4 | 25 | meiotic chromosome separation |
| GO:0072677 | 0.02664 | 3.93430 | 1 | 4 | 25 | eosinophil migration |
| GO:1904861 | 0.02664 | 3.93430 | 1 | 4 | 25 | excitatory synapse assembly |
| GO:2000482 | 0.02664 | 3.93430 | 1 | 4 | 25 | regulation of interleukin-8 secretion |
| GO:0050905 | 0.02664 | 2.13517 | 5 | 10 | 107 | neuromuscular process |
| GO:0038083 | 0.02692 | 3.22911 | 2 | 5 | 37 | peptidyl-tyrosine autophosphorylation |
| GO:0060323 | 0.02692 | 3.22911 | 2 | 5 | 37 | head morphogenesis |
| GO:0014009 | 0.02725 | 2.81950 | 2 | 6 | 50 | glial cell proliferation |
| GO:0098656 | 0.02739 | 1.63435 | 13 | 21 | 288 | anion transmembrane transport |
| GO:0051928 | 0.02762 | 2.03478 | 6 | 11 | 123 | positive regulation of calcium ion transport |
| GO:0051347 | 0.02769 | 1.40736 | 30 | 41 | 649 | positive regulation of transferase activity |
| GO:0048247 | 0.02810 | 2.54030 | 3 | 7 | 64 | lymphocyte chemotaxis |
| GO:0050922 | 0.02810 | 2.54030 | 3 | 7 | 64 | negative regulation of chemotaxis |
| GO:0006821 | 0.02819 | 2.11326 | 5 | 10 | 108 | chloride transport |
| GO:0051225 | 0.02819 | 2.11326 | 5 | 10 | 108 | spindle assembly |
| GO:2000278 | 0.02819 | 2.11326 | 5 | 10 | 108 | regulation of DNA biosynthetic process |
| GO:0071363 | 0.02829 | 1.38784 | 33 | 44 | 706 | cellular response to growth factor stimulus |
| GO:0001957 | 0.02840 | 10.31344 | 0 | 2 | 6 | intramembranous ossification |
| GO:0002396 | 0.02840 | 10.31344 | 0 | 2 | 6 | MHC protein complex assembly |
| GO:0002767 | 0.02840 | 10.31344 | 0 | 2 | 6 | immune response-inhibiting cell surface receptor signaling pathway |
| GO:0003096 | 0.02840 | 10.31344 | 0 | 2 | 6 | renal sodium ion transport |
| GO:0010641 | 0.02840 | 10.31344 | 0 | 2 | 6 | positive regulation of platelet-derived growth factor receptor signaling pathway |
| GO:0010871 | 0.02840 | 10.31344 | 0 | 2 | 6 | negative regulation of receptor biosynthetic process |
| GO:0016198 | 0.02840 | 10.31344 | 0 | 2 | 6 | axon choice point recognition |
| GO:0032415 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of sodium:proton antiporter activity |
| GO:0032803 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of low-density lipoprotein particle receptor catabolic process |
| GO:0032962 | 0.02840 | 10.31344 | 0 | 2 | 6 | positive regulation of inositol trisphosphate biosynthetic process |
| GO:0034238 | 0.02840 | 10.31344 | 0 | 2 | 6 | macrophage fusion |
| GO:0035931 | 0.02840 | 10.31344 | 0 | 2 | 6 | mineralocorticoid secretion |
| GO:0035932 | 0.02840 | 10.31344 | 0 | 2 | 6 | aldosterone secretion |
| GO:0036072 | 0.02840 | 10.31344 | 0 | 2 | 6 | direct ossification |
| GO:0038031 | 0.02840 | 10.31344 | 0 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:0044245 | 0.02840 | 10.31344 | 0 | 2 | 6 | polysaccharide digestion |
| GO:0051665 | 0.02840 | 10.31344 | 0 | 2 | 6 | membrane raft localization |
| GO:0060482 | 0.02840 | 10.31344 | 0 | 2 | 6 | lobar bronchus development |
| GO:0060685 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of prostatic bud formation |
| GO:0072298 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of metanephric glomerulus development |
| GO:0090306 | 0.02840 | 10.31344 | 0 | 2 | 6 | spindle assembly involved in meiosis |
| GO:0090678 | 0.02840 | 10.31344 | 0 | 2 | 6 | cell dedifferentiation involved in phenotypic switching |
| GO:0097283 | 0.02840 | 10.31344 | 0 | 2 | 6 | keratinocyte apoptotic process |
| GO:1900748 | 0.02840 | 10.31344 | 0 | 2 | 6 | positive regulation of vascular endothelial growth factor signaling pathway |
| GO:1901164 | 0.02840 | 10.31344 | 0 | 2 | 6 | negative regulation of trophoblast cell migration |
| GO:1902172 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of keratinocyte apoptotic process |
| GO:1903613 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of protein tyrosine phosphatase activity |
| GO:1905174 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of vascular smooth muscle cell dedifferentiation |
| GO:1990936 | 0.02840 | 10.31344 | 0 | 2 | 6 | vascular smooth muscle cell dedifferentiation |
| GO:2000855 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of mineralocorticoid secretion |
| GO:2000858 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of aldosterone secretion |
| GO:2001033 | 0.02840 | 10.31344 | 0 | 2 | 6 | negative regulation of double-strand break repair via nonhomologous end joining |
| GO:2001188 | 0.02840 | 10.31344 | 0 | 2 | 6 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0014013 | 0.02909 | 2.01666 | 6 | 11 | 124 | regulation of gliogenesis |
| GO:0046717 | 0.02909 | 2.01666 | 6 | 11 | 124 | acid secretion |
| GO:0051101 | 0.02909 | 2.01666 | 6 | 11 | 124 | regulation of DNA binding |
| GO:0034330 | 0.02924 | 1.62202 | 13 | 21 | 290 | cell junction organization |
| GO:0050678 | 0.02940 | 1.53652 | 18 | 26 | 378 | regulation of epithelial cell proliferation |
| GO:0046330 | 0.02949 | 1.94281 | 6 | 12 | 140 | positive regulation of JNK cascade |
| GO:0097553 | 0.02949 | 1.94281 | 6 | 12 | 140 | calcium ion transmembrane import into cytosol |
| GO:0033002 | 0.02968 | 1.69089 | 11 | 18 | 239 | muscle cell proliferation |
| GO:0032645 | 0.02972 | 5.16038 | 1 | 3 | 15 | regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0033604 | 0.02972 | 5.16038 | 1 | 3 | 15 | negative regulation of catecholamine secretion |
| GO:0046321 | 0.02972 | 5.16038 | 1 | 3 | 15 | positive regulation of fatty acid oxidation |
| GO:0060099 | 0.02972 | 5.16038 | 1 | 3 | 15 | regulation of phagocytosis, engulfment |
| GO:0070571 | 0.02972 | 5.16038 | 1 | 3 | 15 | negative regulation of neuron projection regeneration |
| GO:0090192 | 0.02972 | 5.16038 | 1 | 3 | 15 | regulation of glomerulus development |
| GO:0098840 | 0.02972 | 5.16038 | 1 | 3 | 15 | protein transport along microtubule |
| GO:0099118 | 0.02972 | 5.16038 | 1 | 3 | 15 | microtubule-based protein transport |
| GO:1900239 | 0.02972 | 5.16038 | 1 | 3 | 15 | regulation of phenotypic switching |
| GO:1905874 | 0.02972 | 5.16038 | 1 | 3 | 15 | regulation of postsynaptic density organization |
| GO:2000402 | 0.02972 | 5.16038 | 1 | 3 | 15 | negative regulation of lymphocyte migration |
| GO:0007566 | 0.02972 | 2.75669 | 2 | 6 | 51 | embryo implantation |
| GO:0019369 | 0.02972 | 2.75669 | 2 | 6 | 51 | arachidonic acid metabolic process |
| GO:0007223 | 0.02986 | 3.13108 | 2 | 5 | 38 | Wnt signaling pathway, calcium modulating pathway |
| GO:0046676 | 0.02986 | 3.13108 | 2 | 5 | 38 | negative regulation of insulin secretion |
| GO:0048246 | 0.02986 | 3.13108 | 2 | 5 | 38 | macrophage chemotaxis |
| GO:2000279 | 0.02986 | 3.13108 | 2 | 5 | 38 | negative regulation of DNA biosynthetic process |
| GO:0048002 | 0.02997 | 1.78813 | 9 | 15 | 189 | antigen processing and presentation of peptide antigen |
| GO:0002460 | 0.03004 | 1.54735 | 17 | 25 | 361 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0045621 | 0.03006 | 2.19186 | 4 | 9 | 94 | positive regulation of lymphocyte differentiation |
| GO:0065009 | 0.03027 | 1.19172 | 138 | 159 | 2989 | regulation of molecular function |
| GO:0050854 | 0.03028 | 2.49636 | 3 | 7 | 65 | regulation of antigen receptor-mediated signaling pathway |
| GO:0051148 | 0.03028 | 2.49636 | 3 | 7 | 65 | negative regulation of muscle cell differentiation |
| GO:0031954 | 0.03036 | 3.75525 | 1 | 4 | 26 | positive regulation of protein autophosphorylation |
| GO:0042481 | 0.03036 | 3.75525 | 1 | 4 | 26 | regulation of odontogenesis |
| GO:0043567 | 0.03036 | 3.75525 | 1 | 4 | 26 | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0048596 | 0.03036 | 3.75525 | 1 | 4 | 26 | embryonic camera-type eye morphogenesis |
| GO:0050926 | 0.03036 | 3.75525 | 1 | 4 | 26 | regulation of positive chemotaxis |
| GO:0060706 | 0.03036 | 3.75525 | 1 | 4 | 26 | cell differentiation involved in embryonic placenta development |
| GO:0071711 | 0.03036 | 3.75525 | 1 | 4 | 26 | basement membrane organization |
| GO:1900120 | 0.03036 | 3.75525 | 1 | 4 | 26 | regulation of receptor binding |
| GO:0050679 | 0.03044 | 1.74719 | 10 | 16 | 206 | positive regulation of epithelial cell proliferation |
| GO:0001659 | 0.03052 | 1.82578 | 8 | 14 | 173 | temperature homeostasis |
| GO:0006813 | 0.03076 | 1.68317 | 11 | 18 | 240 | potassium ion transport |
| GO:0001764 | 0.03086 | 1.87136 | 7 | 13 | 157 | neuron migration |
| GO:0043271 | 0.03086 | 1.87136 | 7 | 13 | 157 | negative regulation of ion transport |
| GO:0009411 | 0.03093 | 1.92764 | 7 | 12 | 141 | response to UV |
| GO:0033559 | 0.03148 | 2.07076 | 5 | 10 | 110 | unsaturated fatty acid metabolic process |
| GO:0002088 | 0.03163 | 2.29911 | 4 | 8 | 80 | lens development in camera-type eye |
| GO:0033045 | 0.03163 | 2.29911 | 4 | 8 | 80 | regulation of sister chromatid segregation |
| GO:0034329 | 0.03187 | 1.67553 | 11 | 18 | 241 | cell junction assembly |
| GO:0090092 | 0.03187 | 1.67553 | 11 | 18 | 241 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0007346 | 0.03210 | 1.39078 | 30 | 41 | 656 | regulation of mitotic cell cycle |
| GO:0060402 | 0.03227 | 1.85835 | 7 | 13 | 158 | calcium ion transport into cytosol |
| GO:0009620 | 0.03233 | 2.69661 | 2 | 6 | 52 | response to fungus |
| GO:0032731 | 0.03233 | 2.69661 | 2 | 6 | 52 | positive regulation of interleukin-1 beta production |
| GO:0045839 | 0.03233 | 2.69661 | 2 | 6 | 52 | negative regulation of mitotic nuclear division |
| GO:0046888 | 0.03257 | 2.45391 | 3 | 7 | 66 | negative regulation of hormone secretion |
| GO:0030501 | 0.03299 | 3.03882 | 2 | 5 | 39 | positive regulation of bone mineralization |
| GO:0042417 | 0.03299 | 3.03882 | 2 | 5 | 39 | dopamine metabolic process |
| GO:0051930 | 0.03299 | 3.03882 | 2 | 5 | 39 | regulation of sensory perception of pain |
| GO:1905521 | 0.03299 | 3.03882 | 2 | 5 | 39 | regulation of macrophage migration |
| GO:0060429 | 0.03304 | 1.27514 | 60 | 74 | 1291 | epithelium development |
| GO:0002478 | 0.03319 | 1.80289 | 8 | 14 | 175 | antigen processing and presentation of exogenous peptide antigen |
| GO:0031623 | 0.03322 | 2.05014 | 5 | 10 | 111 | receptor internalization |
| GO:0060761 | 0.03373 | 2.26748 | 4 | 8 | 81 | negative regulation of response to cytokine stimulus |
| GO:0097327 | 0.03381 | 2.14123 | 4 | 9 | 96 | response to antineoplastic agent |
| GO:0099024 | 0.03385 | 1.96417 | 6 | 11 | 127 | plasma membrane invagination |
| GO:0001655 | 0.03411 | 1.55692 | 15 | 23 | 330 | urogenital system development |
| GO:0051701 | 0.03412 | 1.71974 | 10 | 16 | 209 | interaction with host |
| GO:0019882 | 0.03424 | 1.68780 | 10 | 17 | 226 | antigen processing and presentation |
| GO:0006706 | 0.03438 | 3.59178 | 1 | 4 | 27 | steroid catabolic process |
| GO:0010971 | 0.03438 | 3.59178 | 1 | 4 | 27 | positive regulation of G2/M transition of mitotic cell cycle |
| GO:0035883 | 0.03438 | 3.59178 | 1 | 4 | 27 | enteroendocrine cell differentiation |
| GO:0036336 | 0.03438 | 3.59178 | 1 | 4 | 27 | dendritic cell migration |
| GO:0043032 | 0.03438 | 3.59178 | 1 | 4 | 27 | positive regulation of macrophage activation |
| GO:0043921 | 0.03438 | 3.59178 | 1 | 4 | 27 | modulation by host of viral transcription |
| GO:0045671 | 0.03438 | 3.59178 | 1 | 4 | 27 | negative regulation of osteoclast differentiation |
| GO:0051953 | 0.03438 | 3.59178 | 1 | 4 | 27 | negative regulation of amine transport |
| GO:0052472 | 0.03438 | 3.59178 | 1 | 4 | 27 | modulation by host of symbiont transcription |
| GO:0060384 | 0.03438 | 3.59178 | 1 | 4 | 27 | innervation |
| GO:1901623 | 0.03438 | 3.59178 | 1 | 4 | 27 | regulation of lymphocyte chemotaxis |
| GO:0070997 | 0.03440 | 1.53970 | 16 | 24 | 348 | neuron death |
| GO:0051705 | 0.03498 | 2.41288 | 3 | 7 | 67 | multi-organism behavior |
| GO:0002065 | 0.03503 | 2.02993 | 5 | 10 | 112 | columnar/cuboidal epithelial cell differentiation |
| GO:0015918 | 0.03503 | 2.02993 | 5 | 10 | 112 | sterol transport |
| GO:0048593 | 0.03503 | 2.02993 | 5 | 10 | 112 | camera-type eye morphogenesis |
| GO:0071320 | 0.03508 | 2.63909 | 2 | 6 | 53 | cellular response to cAMP |
| GO:1905517 | 0.03508 | 2.63909 | 2 | 6 | 53 | macrophage migration |
| GO:0001977 | 0.03534 | 4.76316 | 1 | 3 | 16 | renal system process involved in regulation of blood volume |
| GO:0006957 | 0.03534 | 4.76316 | 1 | 3 | 16 | complement activation, alternative pathway |
| GO:0007158 | 0.03534 | 4.76316 | 1 | 3 | 16 | neuron cell-cell adhesion |
| GO:0010919 | 0.03534 | 4.76316 | 1 | 3 | 16 | regulation of inositol phosphate biosynthetic process |
| GO:0016114 | 0.03534 | 4.76316 | 1 | 3 | 16 | terpenoid biosynthetic process |
| GO:0032604 | 0.03534 | 4.76316 | 1 | 3 | 16 | granulocyte macrophage colony-stimulating factor production |
| GO:0033033 | 0.03534 | 4.76316 | 1 | 3 | 16 | negative regulation of myeloid cell apoptotic process |
| GO:0042447 | 0.03534 | 4.76316 | 1 | 3 | 16 | hormone catabolic process |
| GO:0042448 | 0.03534 | 4.76316 | 1 | 3 | 16 | progesterone metabolic process |
| GO:0051382 | 0.03534 | 4.76316 | 1 | 3 | 16 | kinetochore assembly |
| GO:0070293 | 0.03534 | 4.76316 | 1 | 3 | 16 | renal absorption |
| GO:0071871 | 0.03534 | 4.76316 | 1 | 3 | 16 | response to epinephrine |
| GO:0072224 | 0.03534 | 4.76316 | 1 | 3 | 16 | metanephric glomerulus development |
| GO:0007178 | 0.03539 | 1.53488 | 16 | 24 | 349 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0030534 | 0.03556 | 1.88351 | 7 | 12 | 144 | adult behavior |
| GO:0051259 | 0.03580 | 1.40995 | 26 | 36 | 568 | protein complex oligomerization |
| GO:0015908 | 0.03580 | 2.11678 | 4 | 9 | 97 | fatty acid transport |
| GO:1990868 | 0.03580 | 2.11678 | 4 | 9 | 97 | response to chemokine |
| GO:1990869 | 0.03580 | 2.11678 | 4 | 9 | 97 | cellular response to chemokine |
| GO:0043549 | 0.03586 | 1.32824 | 40 | 52 | 870 | regulation of kinase activity |
| GO:0034644 | 0.03592 | 2.23672 | 4 | 8 | 82 | cellular response to UV |
| GO:0019835 | 0.03631 | 2.95183 | 2 | 5 | 40 | cytolysis |
| GO:0042036 | 0.03631 | 2.95183 | 2 | 5 | 40 | negative regulation of cytokine biosynthetic process |
| GO:0045124 | 0.03631 | 2.95183 | 2 | 5 | 40 | regulation of bone resorption |
| GO:0051931 | 0.03631 | 2.95183 | 2 | 5 | 40 | regulation of sensory perception |
| GO:0090184 | 0.03631 | 2.95183 | 2 | 5 | 40 | positive regulation of kidney development |
| GO:0060322 | 0.03674 | 1.34587 | 36 | 47 | 776 | head development |
| GO:0009725 | 0.03690 | 1.30559 | 46 | 58 | 987 | response to hormone |
| GO:0043200 | 0.03690 | 2.01011 | 5 | 10 | 113 | response to amino acid |
| GO:0002822 | 0.03721 | 1.86925 | 7 | 12 | 145 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0002292 | 0.03750 | 2.37319 | 3 | 7 | 68 | T cell differentiation involved in immune response |
| GO:0033047 | 0.03750 | 2.37319 | 3 | 7 | 68 | regulation of mitotic sister chromatid segregation |
| GO:0033627 | 0.03750 | 2.37319 | 3 | 7 | 68 | cell adhesion mediated by integrin |
| GO:0051965 | 0.03750 | 2.37319 | 3 | 7 | 68 | positive regulation of synapse assembly |
| GO:0071230 | 0.03750 | 2.37319 | 3 | 7 | 68 | cellular response to amino acid stimulus |
| GO:0099175 | 0.03787 | 2.09288 | 5 | 9 | 98 | regulation of postsynapse organization |
| GO:0002763 | 0.03798 | 2.58396 | 3 | 6 | 54 | positive regulation of myeloid leukocyte differentiation |
| GO:0006584 | 0.03798 | 2.58396 | 3 | 6 | 54 | catecholamine metabolic process |
| GO:0006636 | 0.03798 | 2.58396 | 3 | 6 | 54 | unsaturated fatty acid biosynthetic process |
| GO:0009712 | 0.03798 | 2.58396 | 3 | 6 | 54 | catechol-containing compound metabolic process |
| GO:0061005 | 0.03798 | 2.58396 | 3 | 6 | 54 | cell differentiation involved in kidney development |
| GO:0006796 | 0.03805 | 1.17332 | 154 | 174 | 3320 | phosphate-containing compound metabolic process |
| GO:0045582 | 0.03821 | 2.20677 | 4 | 8 | 83 | positive regulation of T cell differentiation |
| GO:0002248 | 0.03855 | 8.25029 | 0 | 2 | 7 | connective tissue replacement involved in inflammatory response wound healing |
| GO:0003253 | 0.03855 | 8.25029 | 0 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0010046 | 0.03855 | 8.25029 | 0 | 2 | 7 | response to mycotoxin |
| GO:0010760 | 0.03855 | 8.25029 | 0 | 2 | 7 | negative regulation of macrophage chemotaxis |
| GO:0015808 | 0.03855 | 8.25029 | 0 | 2 | 7 | L-alanine transport |
| GO:0019064 | 0.03855 | 8.25029 | 0 | 2 | 7 | fusion of virus membrane with host plasma membrane |
| GO:0032696 | 0.03855 | 8.25029 | 0 | 2 | 7 | negative regulation of interleukin-13 production |
| GO:0032714 | 0.03855 | 8.25029 | 0 | 2 | 7 | negative regulation of interleukin-5 production |
| GO:0032960 | 0.03855 | 8.25029 | 0 | 2 | 7 | regulation of inositol trisphosphate biosynthetic process |
| GO:0033239 | 0.03855 | 8.25029 | 0 | 2 | 7 | negative regulation of cellular amine metabolic process |
| GO:0034154 | 0.03855 | 8.25029 | 0 | 2 | 7 | toll-like receptor 7 signaling pathway |
| GO:0034354 | 0.03855 | 8.25029 | 0 | 2 | 7 | 'de novo' NAD biosynthetic process from tryptophan |
| GO:0034627 | 0.03855 | 8.25029 | 0 | 2 | 7 | 'de novo' NAD biosynthetic process |
| GO:0035482 | 0.03855 | 8.25029 | 0 | 2 | 7 | gastric motility |
| GO:0035524 | 0.03855 | 8.25029 | 0 | 2 | 7 | proline transmembrane transport |
| GO:0038001 | 0.03855 | 8.25029 | 0 | 2 | 7 | paracrine signaling |
| GO:0038030 | 0.03855 | 8.25029 | 0 | 2 | 7 | non-canonical Wnt signaling pathway via MAPK cascade |
| GO:0039663 | 0.03855 | 8.25029 | 0 | 2 | 7 | membrane fusion involved in viral entry into host cell |
| GO:0044800 | 0.03855 | 8.25029 | 0 | 2 | 7 | multi-organism membrane fusion |
| GO:0045084 | 0.03855 | 8.25029 | 0 | 2 | 7 | positive regulation of interleukin-12 biosynthetic process |
| GO:0045650 | 0.03855 | 8.25029 | 0 | 2 | 7 | negative regulation of macrophage differentiation |
| GO:0045654 | 0.03855 | 8.25029 | 0 | 2 | 7 | positive regulation of megakaryocyte differentiation |
| GO:0048341 | 0.03855 | 8.25029 | 0 | 2 | 7 | paraxial mesoderm formation |
| GO:0051964 | 0.03855 | 8.25029 | 0 | 2 | 7 | negative regulation of synapse assembly |
| GO:0060013 | 0.03855 | 8.25029 | 0 | 2 | 7 | righting reflex |
| GO:0060753 | 0.03855 | 8.25029 | 0 | 2 | 7 | regulation of mast cell chemotaxis |
| GO:0061518 | 0.03855 | 8.25029 | 0 | 2 | 7 | microglial cell proliferation |
| GO:0072615 | 0.03855 | 8.25029 | 0 | 2 | 7 | interleukin-17 secretion |
| GO:0097052 | 0.03855 | 8.25029 | 0 | 2 | 7 | L-kynurenine metabolic process |
| GO:1900223 | 0.03855 | 8.25029 | 0 | 2 | 7 | positive regulation of amyloid-beta clearance |
| GO:1901509 | 0.03855 | 8.25029 | 0 | 2 | 7 | regulation of endothelial tube morphogenesis |
| GO:1904124 | 0.03855 | 8.25029 | 0 | 2 | 7 | microglial cell migration |
| GO:1904139 | 0.03855 | 8.25029 | 0 | 2 | 7 | regulation of microglial cell migration |
| GO:1990791 | 0.03855 | 8.25029 | 0 | 2 | 7 | dorsal root ganglion development |
| GO:0001516 | 0.03868 | 3.44193 | 1 | 4 | 28 | prostaglandin biosynthetic process |
| GO:0010818 | 0.03868 | 3.44193 | 1 | 4 | 28 | T cell chemotaxis |
| GO:0018146 | 0.03868 | 3.44193 | 1 | 4 | 28 | keratan sulfate biosynthetic process |
| GO:0032770 | 0.03868 | 3.44193 | 1 | 4 | 28 | positive regulation of monooxygenase activity |
| GO:0033598 | 0.03868 | 3.44193 | 1 | 4 | 28 | mammary gland epithelial cell proliferation |
| GO:0045408 | 0.03868 | 3.44193 | 1 | 4 | 28 | regulation of interleukin-6 biosynthetic process |
| GO:0046457 | 0.03868 | 3.44193 | 1 | 4 | 28 | prostanoid biosynthetic process |
| GO:0050858 | 0.03868 | 3.44193 | 1 | 4 | 28 | negative regulation of antigen receptor-mediated signaling pathway |
| GO:0052312 | 0.03868 | 3.44193 | 1 | 4 | 28 | modulation of transcription in other organism involved in symbiotic interaction |
| GO:0060512 | 0.03868 | 3.44193 | 1 | 4 | 28 | prostate gland morphogenesis |
| GO:0090344 | 0.03868 | 3.44193 | 1 | 4 | 28 | negative regulation of cell aging |
| GO:0001667 | 0.03889 | 1.44830 | 21 | 30 | 461 | ameboidal-type cell migration |
| GO:0000086 | 0.03914 | 1.63107 | 11 | 18 | 247 | G2/M transition of mitotic cell cycle |
| GO:0051173 | 0.03928 | 1.17440 | 148 | 168 | 3200 | positive regulation of nitrogen compound metabolic process |
| GO:0010389 | 0.03942 | 1.71830 | 9 | 15 | 196 | regulation of G2/M transition of mitotic cell cycle |
| GO:1902749 | 0.03953 | 1.68444 | 10 | 16 | 213 | regulation of cell cycle G2/M phase transition |
| GO:0010955 | 0.03984 | 2.86967 | 2 | 5 | 41 | negative regulation of protein processing |
| GO:1903318 | 0.03984 | 2.86967 | 2 | 5 | 41 | negative regulation of protein maturation |
| GO:0033674 | 0.03989 | 1.39642 | 27 | 36 | 573 | positive regulation of kinase activity |
| GO:0097479 | 0.03997 | 1.79589 | 8 | 13 | 163 | synaptic vesicle localization |
| GO:1902600 | 0.03997 | 1.79589 | 8 | 13 | 163 | proton transmembrane transport |
| GO:1902531 | 0.04007 | 1.21449 | 91 | 107 | 1961 | regulation of intracellular signal transduction |
| GO:0050771 | 0.04013 | 2.33478 | 3 | 7 | 69 | negative regulation of axonogenesis |
| GO:0006793 | 0.04038 | 1.17001 | 155 | 175 | 3347 | phosphorus metabolic process |
| GO:0050886 | 0.04059 | 2.17761 | 4 | 8 | 84 | endocrine process |
| GO:0071346 | 0.04062 | 1.74809 | 8 | 14 | 180 | cellular response to interferon-gamma |
| GO:0061351 | 0.04066 | 1.84134 | 7 | 12 | 147 | neural precursor cell proliferation |
| GO:0002090 | 0.04103 | 2.53109 | 3 | 6 | 55 | regulation of receptor internalization |
| GO:0043113 | 0.04103 | 2.53109 | 3 | 6 | 55 | receptor clustering |
| GO:0044839 | 0.04127 | 1.59647 | 12 | 19 | 266 | cell cycle G2/M phase transition |
| GO:0044770 | 0.04144 | 1.37284 | 29 | 39 | 631 | cell cycle phase transition |
| GO:0006586 | 0.04148 | 4.42269 | 1 | 3 | 17 | indolalkylamine metabolic process |
| GO:0035988 | 0.04148 | 4.42269 | 1 | 3 | 17 | chondrocyte proliferation |
| GO:0045725 | 0.04148 | 4.42269 | 1 | 3 | 17 | positive regulation of glycogen biosynthetic process |
| GO:0061318 | 0.04148 | 4.42269 | 1 | 3 | 17 | renal filtration cell differentiation |
| GO:0072112 | 0.04148 | 4.42269 | 1 | 3 | 17 | glomerular visceral epithelial cell differentiation |
| GO:0098856 | 0.04148 | 4.42269 | 1 | 3 | 17 | intestinal lipid absorption |
| GO:1902683 | 0.04148 | 4.42269 | 1 | 3 | 17 | regulation of receptor localization to synapse |
| GO:1904355 | 0.04148 | 4.42269 | 1 | 3 | 17 | positive regulation of telomere capping |
| GO:0051098 | 0.04179 | 1.49297 | 17 | 25 | 373 | regulation of binding |
| GO:0021700 | 0.04189 | 1.57262 | 13 | 20 | 284 | developmental maturation |
| GO:0060079 | 0.04226 | 2.04665 | 5 | 9 | 100 | excitatory postsynaptic potential |
| GO:0014065 | 0.04247 | 1.82770 | 7 | 12 | 148 | phosphatidylinositol 3-kinase signaling |
| GO:0072376 | 0.04247 | 1.69932 | 9 | 15 | 198 | protein activation cascade |
| GO:0001756 | 0.04289 | 2.29759 | 3 | 7 | 70 | somitogenesis |
| GO:0061515 | 0.04289 | 2.29759 | 3 | 7 | 70 | myeloid cell development |
| GO:1904705 | 0.04307 | 2.14921 | 4 | 8 | 85 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.04307 | 2.14921 | 4 | 8 | 85 | vascular smooth muscle cell proliferation |
| GO:0010951 | 0.04319 | 1.60971 | 12 | 18 | 250 | negative regulation of endopeptidase activity |
| GO:0000083 | 0.04328 | 3.30407 | 1 | 4 | 29 | regulation of transcription involved in G1/S transition of mitotic cell cycle |
| GO:0008299 | 0.04328 | 3.30407 | 1 | 4 | 29 | isoprenoid biosynthetic process |
| GO:0033032 | 0.04328 | 3.30407 | 1 | 4 | 29 | regulation of myeloid cell apoptotic process |
| GO:0042226 | 0.04328 | 3.30407 | 1 | 4 | 29 | interleukin-6 biosynthetic process |
| GO:0055075 | 0.04328 | 3.30407 | 1 | 4 | 29 | potassium ion homeostasis |
| GO:0060536 | 0.04328 | 3.30407 | 1 | 4 | 29 | cartilage morphogenesis |
| GO:0072606 | 0.04328 | 3.30407 | 1 | 4 | 29 | interleukin-8 secretion |
| GO:0010470 | 0.04357 | 2.79195 | 2 | 5 | 42 | regulation of gastrulation |
| GO:0031641 | 0.04357 | 2.79195 | 2 | 5 | 42 | regulation of myelination |
| GO:0097028 | 0.04357 | 2.79195 | 2 | 5 | 42 | dendritic cell differentiation |
| GO:0034341 | 0.04406 | 1.68999 | 9 | 15 | 199 | response to interferon-gamma |
| GO:0061061 | 0.04420 | 1.35425 | 31 | 41 | 672 | muscle structure development |
| GO:0001912 | 0.04423 | 2.48033 | 3 | 6 | 56 | positive regulation of leukocyte mediated cytotoxicity |
| GO:0034508 | 0.04423 | 2.48033 | 3 | 6 | 56 | centromere complex assembly |
| GO:0090183 | 0.04423 | 2.48033 | 3 | 6 | 56 | regulation of kidney development |
| GO:2001056 | 0.04433 | 1.81426 | 7 | 12 | 149 | positive regulation of cysteine-type endopeptidase activity |
| GO:0060828 | 0.04451 | 1.56062 | 13 | 20 | 286 | regulation of canonical Wnt signaling pathway |
| GO:0001508 | 0.04495 | 1.86694 | 6 | 11 | 133 | action potential |
| GO:0009581 | 0.04495 | 1.86694 | 6 | 11 | 133 | detection of external stimulus |
| GO:0043393 | 0.04552 | 1.65055 | 10 | 16 | 217 | regulation of protein binding |
| GO:0050770 | 0.04560 | 1.71677 | 8 | 14 | 183 | regulation of axonogenesis |
| GO:0003333 | 0.04564 | 2.12153 | 4 | 8 | 86 | amino acid transmembrane transport |
| GO:0030101 | 0.04564 | 2.12153 | 4 | 8 | 86 | natural killer cell activation |
| GO:0051057 | 0.04576 | 2.26156 | 3 | 7 | 71 | positive regulation of small GTPase mediated signal transduction |
| GO:0035567 | 0.04625 | 1.80101 | 7 | 12 | 150 | non-canonical Wnt signaling pathway |
| GO:0000256 | 0.04633 | Inf | 0 | 1 | 1 | allantoin catabolic process |
| GO:0000741 | 0.04633 | Inf | 0 | 1 | 1 | karyogamy |
| GO:0000921 | 0.04633 | Inf | 0 | 1 | 1 | septin ring assembly |
| GO:0001080 | 0.04633 | Inf | 0 | 1 | 1 | nitrogen catabolite activation of transcription from RNA polymerase II promoter |
| GO:0001797 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of type IIa hypersensitivity |
| GO:0001811 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of type I hypersensitivity |
| GO:0001814 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of antibody-dependent cellular cytotoxicity |
| GO:0002033 | 0.04633 | Inf | 0 | 1 | 1 | angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure |
| GO:0002041 | 0.04633 | Inf | 0 | 1 | 1 | intussusceptive angiogenesis |
| GO:0002290 | 0.04633 | Inf | 0 | 1 | 1 | gamma-delta T cell activation involved in immune response |
| GO:0002343 | 0.04633 | Inf | 0 | 1 | 1 | peripheral B cell selection |
| GO:0002344 | 0.04633 | Inf | 0 | 1 | 1 | B cell affinity maturation |
| GO:0002450 | 0.04633 | Inf | 0 | 1 | 1 | B cell antigen processing and presentation |
| GO:0002622 | 0.04633 | Inf | 0 | 1 | 1 | regulation of B cell antigen processing and presentation |
| GO:0002721 | 0.04633 | Inf | 0 | 1 | 1 | regulation of B cell cytokine production |
| GO:0002893 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of type II hypersensitivity |
| GO:0003026 | 0.04633 | Inf | 0 | 1 | 1 | regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback |
| GO:0003131 | 0.04633 | Inf | 0 | 1 | 1 | mesodermal-endodermal cell signaling |
| GO:0003311 | 0.04633 | Inf | 0 | 1 | 1 | pancreatic D cell differentiation |
| GO:0007344 | 0.04633 | Inf | 0 | 1 | 1 | pronuclear fusion |
| GO:0008591 | 0.04633 | Inf | 0 | 1 | 1 | regulation of Wnt signaling pathway, calcium modulating pathway |
| GO:0010037 | 0.04633 | Inf | 0 | 1 | 1 | response to carbon dioxide |
| GO:0010189 | 0.04633 | Inf | 0 | 1 | 1 | vitamin E biosynthetic process |
| GO:0014861 | 0.04633 | Inf | 0 | 1 | 1 | regulation of skeletal muscle contraction via regulation of action potential |
| GO:0015730 | 0.04633 | Inf | 0 | 1 | 1 | propanoate transport |
| GO:0016062 | 0.04633 | Inf | 0 | 1 | 1 | adaptation of rhodopsin mediated signaling |
| GO:0016332 | 0.04633 | Inf | 0 | 1 | 1 | establishment or maintenance of polarity of embryonic epithelium |
| GO:0018277 | 0.04633 | Inf | 0 | 1 | 1 | protein deamination |
| GO:0018350 | 0.04633 | Inf | 0 | 1 | 1 | protein esterification |
| GO:0019546 | 0.04633 | Inf | 0 | 1 | 1 | arginine deiminase pathway |
| GO:0032491 | 0.04633 | Inf | 0 | 1 | 1 | detection of molecule of fungal origin |
| GO:0032605 | 0.04633 | Inf | 0 | 1 | 1 | hepatocyte growth factor production |
| GO:0032646 | 0.04633 | Inf | 0 | 1 | 1 | regulation of hepatocyte growth factor production |
| GO:0032681 | 0.04633 | Inf | 0 | 1 | 1 | regulation of lymphotoxin A production |
| GO:0032685 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of granulocyte macrophage colony-stimulating factor production |
| GO:0032686 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of hepatocyte growth factor production |
| GO:0032752 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of interleukin-3 production |
| GO:0032761 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of lymphotoxin A production |
| GO:0032972 | 0.04633 | Inf | 0 | 1 | 1 | regulation of muscle filament sliding speed |
| GO:0033301 | 0.04633 | Inf | 0 | 1 | 1 | cell cycle comprising mitosis without cytokinesis |
| GO:0033316 | 0.04633 | Inf | 0 | 1 | 1 | meiotic spindle assembly checkpoint |
| GO:0034255 | 0.04633 | Inf | 0 | 1 | 1 | regulation of urea metabolic process |
| GO:0034516 | 0.04633 | Inf | 0 | 1 | 1 | response to vitamin B6 |
| GO:0035238 | 0.04633 | Inf | 0 | 1 | 1 | vitamin A biosynthetic process |
| GO:0035548 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of interferon-beta secretion |
| GO:0035978 | 0.04633 | Inf | 0 | 1 | 1 | histone H2A-S139 phosphorylation |
| GO:0036058 | 0.04633 | Inf | 0 | 1 | 1 | filtration diaphragm assembly |
| GO:0036060 | 0.04633 | Inf | 0 | 1 | 1 | slit diaphragm assembly |
| GO:0036367 | 0.04633 | Inf | 0 | 1 | 1 | light adaption |
| GO:0036517 | 0.04633 | Inf | 0 | 1 | 1 | chemoattraction of serotonergic neuron axon |
| GO:0038118 | 0.04633 | Inf | 0 | 1 | 1 | C-C chemokine receptor CCR7 signaling pathway |
| GO:0038159 | 0.04633 | Inf | 0 | 1 | 1 | C-X-C chemokine receptor CXCR4 signaling pathway |
| GO:0038160 | 0.04633 | Inf | 0 | 1 | 1 | CXCL12-activated CXCR4 signaling pathway |
| GO:0038167 | 0.04633 | Inf | 0 | 1 | 1 | epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity |
| GO:0038168 | 0.04633 | Inf | 0 | 1 | 1 | epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade |
| GO:0038185 | 0.04633 | Inf | 0 | 1 | 1 | intracellular bile acid receptor signaling pathway |
| GO:0038193 | 0.04633 | Inf | 0 | 1 | 1 | thromboxane A2 signaling pathway |
| GO:0042223 | 0.04633 | Inf | 0 | 1 | 1 | interleukin-3 biosynthetic process |
| GO:0043016 | 0.04633 | Inf | 0 | 1 | 1 | regulation of lymphotoxin A biosynthetic process |
| GO:0043017 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of lymphotoxin A biosynthetic process |
| GO:0044779 | 0.04633 | Inf | 0 | 1 | 1 | meiotic spindle checkpoint |
| GO:0045399 | 0.04633 | Inf | 0 | 1 | 1 | regulation of interleukin-3 biosynthetic process |
| GO:0045401 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of interleukin-3 biosynthetic process |
| GO:0045769 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of asymmetric cell division |
| GO:0045813 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of Wnt signaling pathway, calcium modulating pathway |
| GO:0045848 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of nitrogen utilization |
| GO:0046086 | 0.04633 | Inf | 0 | 1 | 1 | adenosine biosynthetic process |
| GO:0046449 | 0.04633 | Inf | 0 | 1 | 1 | creatinine metabolic process |
| GO:0048058 | 0.04633 | Inf | 0 | 1 | 1 | compound eye corneal lens development |
| GO:0048174 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of short-term neuronal synaptic plasticity |
| GO:0048175 | 0.04633 | Inf | 0 | 1 | 1 | hepatocyte growth factor biosynthetic process |
| GO:0048176 | 0.04633 | Inf | 0 | 1 | 1 | regulation of hepatocyte growth factor biosynthetic process |
| GO:0048178 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of hepatocyte growth factor biosynthetic process |
| GO:0048673 | 0.04633 | Inf | 0 | 1 | 1 | collateral sprouting of intact axon in response to injury |
| GO:0048683 | 0.04633 | Inf | 0 | 1 | 1 | regulation of collateral sprouting of intact axon in response to injury |
| GO:0048685 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of collateral sprouting of intact axon in response to injury |
| GO:0048688 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of sprouting of injured axon |
| GO:0048692 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of axon extension involved in regeneration |
| GO:0048792 | 0.04633 | Inf | 0 | 1 | 1 | spontaneous exocytosis of neurotransmitter |
| GO:0050894 | 0.04633 | Inf | 0 | 1 | 1 | determination of affect |
| GO:0051913 | 0.04633 | Inf | 0 | 1 | 1 | regulation of synaptic plasticity by chemical substance |
| GO:0051914 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of synaptic plasticity by chemical substance |
| GO:0051915 | 0.04633 | Inf | 0 | 1 | 1 | induction of synaptic plasticity by chemical substance |
| GO:0060007 | 0.04633 | Inf | 0 | 1 | 1 | linear vestibuloocular reflex |
| GO:0060470 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of cytosolic calcium ion concentration involved in egg activation |
| GO:0060739 | 0.04633 | Inf | 0 | 1 | 1 | mesenchymal-epithelial cell signaling involved in prostate gland development |
| GO:0061347 | 0.04633 | Inf | 0 | 1 | 1 | planar cell polarity pathway involved in outflow tract morphogenesis |
| GO:0061348 | 0.04633 | Inf | 0 | 1 | 1 | planar cell polarity pathway involved in ventricular septum morphogenesis |
| GO:0061349 | 0.04633 | Inf | 0 | 1 | 1 | planar cell polarity pathway involved in cardiac right atrium morphogenesis |
| GO:0061350 | 0.04633 | Inf | 0 | 1 | 1 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis |
| GO:0061354 | 0.04633 | Inf | 0 | 1 | 1 | planar cell polarity pathway involved in pericardium morphogenesis |
| GO:0061782 | 0.04633 | Inf | 0 | 1 | 1 | vesicle fusion with vesicle |
| GO:0061837 | 0.04633 | Inf | 0 | 1 | 1 | neuropeptide processing |
| GO:0070246 | 0.04633 | Inf | 0 | 1 | 1 | natural killer cell apoptotic process |
| GO:0070247 | 0.04633 | Inf | 0 | 1 | 1 | regulation of natural killer cell apoptotic process |
| GO:0070392 | 0.04633 | Inf | 0 | 1 | 1 | detection of lipoteichoic acid |
| GO:0070994 | 0.04633 | Inf | 0 | 1 | 1 | detection of oxidative stress |
| GO:0071258 | 0.04633 | Inf | 0 | 1 | 1 | cellular response to gravity |
| GO:0071529 | 0.04633 | Inf | 0 | 1 | 1 | cementum mineralization |
| GO:0071831 | 0.04633 | Inf | 0 | 1 | 1 | intermediate-density lipoprotein particle clearance |
| GO:0072060 | 0.04633 | Inf | 0 | 1 | 1 | outer medullary collecting duct development |
| GO:0072255 | 0.04633 | Inf | 0 | 1 | 1 | metanephric glomerular mesangial cell development |
| GO:0072721 | 0.04633 | Inf | 0 | 1 | 1 | cellular response to dithiothreitol |
| GO:0085018 | 0.04633 | Inf | 0 | 1 | 1 | maintenance of symbiont-containing vacuole by host |
| GO:0090104 | 0.04633 | Inf | 0 | 1 | 1 | pancreatic epsilon cell differentiation |
| GO:0090294 | 0.04633 | Inf | 0 | 1 | 1 | nitrogen catabolite activation of transcription |
| GO:0090731 | 0.04633 | Inf | 0 | 1 | 1 | cellular response to very-low-density lipoprotein particle stimulus |
| GO:0097310 | 0.04633 | Inf | 0 | 1 | 1 | cap2 mRNA methylation |
| GO:0099050 | 0.04633 | Inf | 0 | 1 | 1 | vesicle scission |
| GO:0099082 | 0.04633 | Inf | 0 | 1 | 1 | retrograde trans-synaptic signaling by neuropeptide |
| GO:0099161 | 0.04633 | Inf | 0 | 1 | 1 | regulation of presynaptic dense core granule exocytosis |
| GO:0099606 | 0.04633 | Inf | 0 | 1 | 1 | microtubule plus-end directed mitotic chromosome migration |
| GO:0099607 | 0.04633 | Inf | 0 | 1 | 1 | lateral attachment of mitotic spindle microtubules to kinetochore |
| GO:0140049 | 0.04633 | Inf | 0 | 1 | 1 | regulation of endocardial cushion to mesenchymal transition |
| GO:0140051 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of endocardial cushion to mesenchymal transition |
| GO:1900243 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of synaptic vesicle endocytosis |
| GO:1901296 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment |
| GO:1901630 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of presynaptic membrane organization |
| GO:1901787 | 0.04633 | Inf | 0 | 1 | 1 | benzoyl-CoA metabolic process |
| GO:1901810 | 0.04633 | Inf | 0 | 1 | 1 | beta-carotene metabolic process |
| GO:1902104 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of metaphase/anaphase transition of meiotic cell cycle |
| GO:1902173 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of keratinocyte apoptotic process |
| GO:1902203 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of hepatocyte growth factor receptor signaling pathway |
| GO:1902217 | 0.04633 | Inf | 0 | 1 | 1 | erythrocyte apoptotic process |
| GO:1902250 | 0.04633 | Inf | 0 | 1 | 1 | regulation of erythrocyte apoptotic process |
| GO:1902251 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of erythrocyte apoptotic process |
| GO:1902362 | 0.04633 | Inf | 0 | 1 | 1 | melanocyte apoptotic process |
| GO:1902480 | 0.04633 | Inf | 0 | 1 | 1 | protein localization to mitotic spindle |
| GO:1902618 | 0.04633 | Inf | 0 | 1 | 1 | cellular response to fluoride |
| GO:1903000 | 0.04633 | Inf | 0 | 1 | 1 | regulation of lipid transport across blood brain barrier |
| GO:1903002 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of lipid transport across blood brain barrier |
| GO:1903080 | 0.04633 | Inf | 0 | 1 | 1 | regulation of C-C chemokine receptor CCR7 signaling pathway |
| GO:1903082 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of C-C chemokine receptor CCR7 signaling pathway |
| GO:1903096 | 0.04633 | Inf | 0 | 1 | 1 | protein localization to meiotic spindle midzone |
| GO:1903126 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of centriole-centriole cohesion |
| GO:1903314 | 0.04633 | Inf | 0 | 1 | 1 | regulation of nitrogen cycle metabolic process |
| GO:1903494 | 0.04633 | Inf | 0 | 1 | 1 | response to dehydroepiandrosterone |
| GO:1903496 | 0.04633 | Inf | 0 | 1 | 1 | response to 11-deoxycorticosterone |
| GO:1904073 | 0.04633 | Inf | 0 | 1 | 1 | regulation of trophectodermal cell proliferation |
| GO:1904075 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of trophectodermal cell proliferation |
| GO:1904092 | 0.04633 | Inf | 0 | 1 | 1 | regulation of autophagic cell death |
| GO:1904093 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of autophagic cell death |
| GO:1904298 | 0.04633 | Inf | 0 | 1 | 1 | regulation of transcytosis |
| GO:1904300 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of transcytosis |
| GO:1904301 | 0.04633 | Inf | 0 | 1 | 1 | regulation of maternal process involved in parturition |
| GO:1904303 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of maternal process involved in parturition |
| GO:1904316 | 0.04633 | Inf | 0 | 1 | 1 | response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine |
| GO:1904317 | 0.04633 | Inf | 0 | 1 | 1 | cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine |
| GO:1904400 | 0.04633 | Inf | 0 | 1 | 1 | response to Thyroid stimulating hormone |
| GO:1904701 | 0.04633 | Inf | 0 | 1 | 1 | Wnt-Frizzled-LRP5/6 complex assembly |
| GO:1904711 | 0.04633 | Inf | 0 | 1 | 1 | regulation of Wnt-Frizzled-LRP5/6 complex assembly |
| GO:1904723 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of Wnt-Frizzled-LRP5/6 complex assembly |
| GO:1904897 | 0.04633 | Inf | 0 | 1 | 1 | regulation of hepatic stellate cell proliferation |
| GO:1904899 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of hepatic stellate cell proliferation |
| GO:1904934 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of cell proliferation in midbrain |
| GO:1904955 | 0.04633 | Inf | 0 | 1 | 1 | planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation |
| GO:1905067 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in heart development |
| GO:1905134 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of meiotic chromosome separation |
| GO:1905161 | 0.04633 | Inf | 0 | 1 | 1 | protein localization to phagocytic vesicle |
| GO:1905162 | 0.04633 | Inf | 0 | 1 | 1 | regulation of phagosome maturation |
| GO:1905169 | 0.04633 | Inf | 0 | 1 | 1 | regulation of protein localization to phagocytic vesicle |
| GO:1905171 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of protein localization to phagocytic vesicle |
| GO:1905186 | 0.04633 | Inf | 0 | 1 | 1 | regulation of metaphase/anaphase transition of meiosis I |
| GO:1905188 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of metaphase/anaphase transition of meiosis I |
| GO:1905217 | 0.04633 | Inf | 0 | 1 | 1 | response to astaxanthin |
| GO:1905240 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation |
| GO:1905291 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of CAMKK-AMPK signaling cascade |
| GO:1905359 | 0.04633 | Inf | 0 | 1 | 1 | protein localization to meiotic spindle |
| GO:1905414 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of dense core granule exocytosis |
| GO:1905415 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of dense core granule exocytosis |
| GO:1905432 | 0.04633 | Inf | 0 | 1 | 1 | regulation of retrograde trans-synaptic signaling by neuropeptide |
| GO:1905433 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of retrograde trans-synaptic signaling by neuropeptide |
| GO:1905468 | 0.04633 | Inf | 0 | 1 | 1 | regulation of clathrin-coated pit assembly |
| GO:1905469 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of clathrin-coated pit assembly |
| GO:1905607 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of presynapse assembly |
| GO:1905693 | 0.04633 | Inf | 0 | 1 | 1 | regulation of phosphatidic acid biosynthetic process |
| GO:1905695 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of phosphatidic acid biosynthetic process |
| GO:1905834 | 0.04633 | Inf | 0 | 1 | 1 | response to pyrimidine ribonucleotide |
| GO:1905835 | 0.04633 | Inf | 0 | 1 | 1 | cellular response to pyrimidine ribonucleotide |
| GO:1905853 | 0.04633 | Inf | 0 | 1 | 1 | regulation of heparan sulfate binding |
| GO:1905855 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of heparan sulfate binding |
| GO:1905858 | 0.04633 | Inf | 0 | 1 | 1 | regulation of heparan sulfate proteoglycan binding |
| GO:1905860 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of heparan sulfate proteoglycan binding |
| GO:1905875 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of postsynaptic density organization |
| GO:1905878 | 0.04633 | Inf | 0 | 1 | 1 | invadopodium disassembly |
| GO:1905890 | 0.04633 | Inf | 0 | 1 | 1 | regulation of cellular response to very-low-density lipoprotein particle stimulus |
| GO:1905927 | 0.04633 | Inf | 0 | 1 | 1 | regulation of invadopodium disassembly |
| GO:1905929 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of invadopodium disassembly |
| GO:1990922 | 0.04633 | Inf | 0 | 1 | 1 | hepatic stellate cell proliferation |
| GO:1990949 | 0.04633 | Inf | 0 | 1 | 1 | metaphase/anaphase transition of meiosis I |
| GO:2000119 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of sodium-dependent phosphate transport |
| GO:2000213 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of glutamate metabolic process |
| GO:2000230 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of pancreatic stellate cell proliferation |
| GO:2000350 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of CD40 signaling pathway |
| GO:2000408 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of T cell extravasation |
| GO:2000431 | 0.04633 | Inf | 0 | 1 | 1 | regulation of cytokinesis, actomyosin contractile ring assembly |
| GO:2000477 | 0.04633 | Inf | 0 | 1 | 1 | regulation of metanephric glomerular visceral epithelial cell development |
| GO:2000478 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of metanephric glomerular visceral epithelial cell development |
| GO:2000534 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of renal albumin absorption |
| GO:2000590 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of metanephric mesenchymal cell migration |
| GO:2000685 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of cellular response to X-ray |
| GO:2000751 | 0.04633 | Inf | 0 | 1 | 1 | histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore |
| GO:2000800 | 0.04633 | Inf | 0 | 1 | 1 | regulation of endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:2000802 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation |
| GO:2001112 | 0.04633 | Inf | 0 | 1 | 1 | regulation of cellular response to hepatocyte growth factor stimulus |
| GO:2001113 | 0.04633 | Inf | 0 | 1 | 1 | negative regulation of cellular response to hepatocyte growth factor stimulus |
| GO:2001191 | 0.04633 | Inf | 0 | 1 | 1 | regulation of gamma-delta T cell activation involved in immune response |
| GO:2001193 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of gamma-delta T cell activation involved in immune response |
| GO:2001248 | 0.04633 | Inf | 0 | 1 | 1 | regulation of ammonia assimilation cycle |
| GO:2001250 | 0.04633 | Inf | 0 | 1 | 1 | positive regulation of ammonia assimilation cycle |
| GO:0002764 | 0.04680 | 1.34761 | 31 | 41 | 675 | immune response-regulating signaling pathway |
| GO:0035335 | 0.04697 | 2.00241 | 5 | 9 | 102 | peptidyl-tyrosine dephosphorylation |
| GO:2000379 | 0.04697 | 2.00241 | 5 | 9 | 102 | positive regulation of reactive oxygen species metabolic process |
| GO:0006911 | 0.04732 | 1.91650 | 5 | 10 | 118 | phagocytosis, engulfment |
| GO:0030866 | 0.04749 | 2.71833 | 2 | 5 | 43 | cortical actin cytoskeleton organization |
| GO:0032924 | 0.04749 | 2.71833 | 2 | 5 | 43 | activin receptor signaling pathway |
| GO:0042088 | 0.04749 | 2.71833 | 2 | 5 | 43 | T-helper 1 type immune response |
| GO:0045429 | 0.04749 | 2.71833 | 2 | 5 | 43 | positive regulation of nitric oxide biosynthetic process |
| GO:0099054 | 0.04749 | 2.71833 | 2 | 5 | 43 | presynapse assembly |
| GO:1990573 | 0.04749 | 2.71833 | 2 | 5 | 43 | potassium ion import across plasma membrane |
| GO:0043525 | 0.04758 | 2.43156 | 3 | 6 | 57 | positive regulation of neuron apoptotic process |
| GO:0071398 | 0.04758 | 2.43156 | 3 | 6 | 57 | cellular response to fatty acid |
| GO:0036035 | 0.04811 | 4.12761 | 1 | 3 | 18 | osteoclast development |
| GO:0036166 | 0.04811 | 4.12761 | 1 | 3 | 18 | phenotypic switching |
| GO:0045780 | 0.04811 | 4.12761 | 1 | 3 | 18 | positive regulation of bone resorption |
| GO:0046852 | 0.04811 | 4.12761 | 1 | 3 | 18 | positive regulation of bone remodeling |
| GO:0048339 | 0.04811 | 4.12761 | 1 | 3 | 18 | paraxial mesoderm development |
| GO:0070633 | 0.04811 | 4.12761 | 1 | 3 | 18 | transepithelial transport |
| GO:0070875 | 0.04811 | 4.12761 | 1 | 3 | 18 | positive regulation of glycogen metabolic process |
| GO:0072311 | 0.04811 | 4.12761 | 1 | 3 | 18 | glomerular epithelial cell differentiation |
| GO:0150078 | 0.04811 | 4.12761 | 1 | 3 | 18 | positive regulation of neuroinflammatory response |
| GO:2000047 | 0.04811 | 4.12761 | 1 | 3 | 18 | regulation of cell-cell adhesion mediated by cadherin |
| GO:0010743 | 0.04818 | 3.17681 | 1 | 4 | 30 | regulation of macrophage derived foam cell differentiation |
| GO:0046320 | 0.04818 | 3.17681 | 1 | 4 | 30 | regulation of fatty acid oxidation |
| GO:0046640 | 0.04818 | 3.17681 | 1 | 4 | 30 | regulation of alpha-beta T cell proliferation |
| GO:0070168 | 0.04818 | 3.17681 | 1 | 4 | 30 | negative regulation of biomineral tissue development |
| GO:0071549 | 0.04818 | 3.17681 | 1 | 4 | 30 | cellular response to dexamethasone stimulus |
| GO:1902751 | 0.04818 | 3.17681 | 1 | 4 | 30 | positive regulation of cell cycle G2/M phase transition |
| GO:0014068 | 0.04832 | 2.09456 | 4 | 8 | 87 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0048477 | 0.04832 | 2.09456 | 4 | 8 | 87 | oogenesis |
| GO:0019226 | 0.04875 | 2.22665 | 3 | 7 | 72 | transmission of nerve impulse |
| GO:0061035 | 0.04875 | 2.22665 | 3 | 7 | 72 | regulation of cartilage development |
| GO:0050806 | 0.04890 | 1.73747 | 8 | 13 | 168 | positive regulation of synaptic transmission |
| GO:1990138 | 0.04890 | 1.73747 | 8 | 13 | 168 | neuron projection extension |
| GO:0043687 | 0.04899 | 1.47921 | 17 | 24 | 361 | post-translational protein modification |
| GO:0007369 | 0.04915 | 1.69650 | 9 | 14 | 185 | gastrulation |
| GO:1902106 | 0.04945 | 1.98100 | 5 | 9 | 103 | negative regulation of leukocyte differentiation |
| GO:0001514 | 0.04985 | 6.87486 | 0 | 2 | 8 | selenocysteine incorporation |
| GO:0002016 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of blood volume by renin-angiotensin |
| GO:0002072 | 0.04985 | 6.87486 | 0 | 2 | 8 | optic cup morphogenesis involved in camera-type eye development |
| GO:0002246 | 0.04985 | 6.87486 | 0 | 2 | 8 | wound healing involved in inflammatory response |
| GO:0002866 | 0.04985 | 6.87486 | 0 | 2 | 8 | positive regulation of acute inflammatory response to antigenic stimulus |
| GO:0002883 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of hypersensitivity |
| GO:0006451 | 0.04985 | 6.87486 | 0 | 2 | 8 | translational readthrough |
| GO:0010966 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of phosphate transport |
| GO:0030853 | 0.04985 | 6.87486 | 0 | 2 | 8 | negative regulation of granulocyte differentiation |
| GO:0030854 | 0.04985 | 6.87486 | 0 | 2 | 8 | positive regulation of granulocyte differentiation |
| GO:0042492 | 0.04985 | 6.87486 | 0 | 2 | 8 | gamma-delta T cell differentiation |
| GO:0045144 | 0.04985 | 6.87486 | 0 | 2 | 8 | meiotic sister chromatid segregation |
| GO:0048539 | 0.04985 | 6.87486 | 0 | 2 | 8 | bone marrow development |
| GO:0051177 | 0.04985 | 6.87486 | 0 | 2 | 8 | meiotic sister chromatid cohesion |
| GO:0051584 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
| GO:0051940 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of catecholamine uptake involved in synaptic transmission |
| GO:0060054 | 0.04985 | 6.87486 | 0 | 2 | 8 | positive regulation of epithelial cell proliferation involved in wound healing |
| GO:0060534 | 0.04985 | 6.87486 | 0 | 2 | 8 | trachea cartilage development |
| GO:0060638 | 0.04985 | 6.87486 | 0 | 2 | 8 | mesenchymal-epithelial cell signaling |
| GO:0061043 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of vascular wound healing |
| GO:0070444 | 0.04985 | 6.87486 | 0 | 2 | 8 | oligodendrocyte progenitor proliferation |
| GO:0070445 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
| GO:0071493 | 0.04985 | 6.87486 | 0 | 2 | 8 | cellular response to UV-B |
| GO:0071864 | 0.04985 | 6.87486 | 0 | 2 | 8 | positive regulation of cell proliferation in bone marrow |
| GO:0098976 | 0.04985 | 6.87486 | 0 | 2 | 8 | excitatory chemical synaptic transmission |
| GO:0099541 | 0.04985 | 6.87486 | 0 | 2 | 8 | trans-synaptic signaling by lipid |
| GO:0099542 | 0.04985 | 6.87486 | 0 | 2 | 8 | trans-synaptic signaling by endocannabinoid |
| GO:2000465 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of glycogen (starch) synthase activity |
| GO:2000483 | 0.04985 | 6.87486 | 0 | 2 | 8 | negative regulation of interleukin-8 secretion |
| GO:2000698 | 0.04985 | 6.87486 | 0 | 2 | 8 | positive regulation of epithelial cell differentiation involved in kidney development |
| GO:2001182 | 0.04985 | 6.87486 | 0 | 2 | 8 | regulation of interleukin-12 secretion |